fluconazole has been researched along with Fungal Lung Diseases in 185 studies
Fluconazole: Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS.
fluconazole : A member of the class of triazoles that is propan-2-ol substituted at position 1 and 3 by 1H-1,2,4-triazol-1-yl groups and at position 2 by a 2,4-difluorophenyl group. It is an antifungal drug used for the treatment of mucosal candidiasis and for systemic infections including systemic candidiasis, coccidioidomycosis, and cryptococcosis.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In previous open-label noncomparative clinical trials, both fluconazole and itraconazole were effective therapy for progressive forms of coccidioidomycosis." | 9.09 | Comparison of oral fluconazole and itraconazole for progressive, nonmeningeal coccidioidomycosis. A randomized, double-blind trial. Mycoses Study Group. ( Catanzaro, A; Cloud, GA; Delgado, KL; Flanigan, C; Galgiani, JN; Johnson, RH; Larsen, RA; Lutz, JE; Mirels, LF; Nassar, F; Rinaldi, MG; Sharkey, PK; Singh, VR; Stevens, DA; Williams, PL, 2000) |
| "To determine the efficacy and safety of fluconazole as treatment for coccidioidomycosis." | 9.08 | Fluconazole in the treatment of chronic pulmonary and nonmeningeal disseminated coccidioidomycosis. NIAID Mycoses Study Group. ( Catanzaro, A; Chapman, SW; Cloud, G; Fierer, J; Galgiani, JN; Levine, BE; Sharkey-Mathis, PK; Stevens, DA, 1995) |
| " Cryptococcus gattii occurs with greater frequency than Cryptococcus neoformans in equine pulmonic cryptococcosis and can be successfully treated with enteral fluconazole monotherapy, with disease severity determining treatment length." | 8.95 | Equine Pulmonary Cryptococcosis: A Comparative Literature Review and Evaluation of Fluconazole Monotherapy. ( Krockenberger, MB; Lester, GD; Secombe, CJ, 2017) |
| "We retrospectively analyzed the medical records and radiographic findings of 10 healthy subjects with isolated pulmonary cryptococcosis diagnosed incidentally and treated with oral fluconazole." | 7.77 | Treatment of asymptomatic pulmonary cryptococcosis in immunocompetent hosts with oral fluconazole. ( Choi, KH; Chung, CR; Han, HJ; Kim, SR; Lee, MH; Lee, YC; Min, KH; Park, SJ, 2011) |
| " We report a case of pulmonary cryptococcosis followed by pleuritis in a patient on fluconazole treatment." | 7.74 | A case of pulmonary cryptococcosis followed by pleuritis in an apparently immunocompetent patient during fluconazole treatment. ( Hayashi, T; Izumikawa, K; Kakeya, H; Kohno, S; Kurihara, S; Miyazaki, T; Miyazaki, Y; Motoshima, K; Nakamura, S; Saijo, T; Seki, M; Takazono, T; Yamamoto, Y; Yanagihara, K; Zhao, Y, 2008) |
| "The current recommended therapy for diffuse coccidioidal pneumonia involves initial treatment with amphotericin B deoxycholate or high-dose fluconazole, followed by an azole after clinical improvement." | 7.73 | Combination therapy of disseminated coccidioidomycosis with caspofungin and fluconazole. ( Cheong, HJ; Kim, JH; Kim, MJ; Kim, WJ; Park, DW; Shin, C; Sohn, JW, 2006) |
| "We treated two cases of primary pulmonary cryptococcosis with fluconazole (FLCZ), the clinical usefulness of FLCZ was evaluated." | 7.70 | [Clinical study on fluconazole (FLCZ) in the treatment of primary pulmonary cryptococcosis]. ( Hayashi, Y; Ito, G; Takeyama, S, 1998) |
| "In order to verify whether fluconazole has a prophylactive effect against the occurrence of cryptococcosis in HIV-infected patients and to identify other factors capable of increasing or reducing the risk of this infection, we arranged a case-control study of 17 patients with cryptococcal infection." | 7.69 | Fluconazole for primary prophylaxis of AIDS-associated cryptococcosis: a case-control study. ( Ammassari, A; Antinori, A; Linzalone, A; Marasca, G; Morace, G; Murri, R, 1995) |
| "Treatment with 200 to 400 mg/day fluconazole was evaluated in 44 patients without AIDS who had cryptococcosis (19 with cryptococcal meningitis, 22 with pulmonary cryptococcosis, 3 with other cryptococcal infections)." | 7.69 | Fluconazole monotherapy for cryptococcosis in non-AIDS patients. ( Hara, K; Ikemoto, H; Ito, A; Kohno, S; Watanabe, K; Yamaguchi, H, 1996) |
| "Disseminated cryptococcosis developed in an HIV antibody positive patient who was taking fluconazole for oral candidiasis." | 7.68 | Cavitating pulmonary cryptococcosis developing in an HIV antibody patient despite prior treatment with fluconazole. ( Bell, D; Coker, RJ; Murphy, SM; Peters, BS, 1992) |
| " Although the patient was on prophylaxis with fluconazole and she did not respond to amphotericin B, there was an excellent response to itraconazole which allowed the transplant without any Aspergillus infection during both the transplant and the post-transplant periods." | 7.68 | [Invasive bronchopulmonary aspergillosis treated with itraconazole in a patient with acute leukemia]. ( Alvarez Blanco, A; Alvarez, C; Floristán, F; Hernández, I; Hernández, J; Ponton, J; Sarcía-Ruiz, JC, 1993) |
| "The efficacy of the combination therapy of fluconazole plus flucytosine against pulmonary cryptococcosis was investigated." | 7.68 | [Pulmonary cryptococcosis treated by combination therapy of fluconazole plus flucytosine]. ( Hara, K; Kaku, M; Koga, H; Kohno, S; Maesaki, S; Mitsutake, K; Miyazaki, H; Miyazaki, T; Tanaka, K; Tomono, K, 1993) |
| "Effects on pulmonary cryptococcosis and aspergillosis and the pharmacokinetics of the new antimycotic agent, fluconazole, were examined." | 7.67 | [The clinical study of fluconazole against pulmonary mycosis. Effects of fluconazole on pulmonary cryptococcosis and aspergillosis, and its pharmacokinetics in patients]. ( Nakashima, M, 1989) |
| "The clinical efficacy of fluconazole at doses of 100-400 mg daily given intravenously in the treatment of 6 cases of deep mycosis complicated with leukemia was evaluated." | 7.67 | [Clinical evaluation of fluconazole in the case of deep mycosis associated with leukemia]. ( Fukawa, H; Kodama, F; Maruta, A; Matsuzaki, M, 1989) |
| "Fluconazole was compared with ketoconazole and with amphotericin B in treatment of pulmonary histoplasmosis in immunologically intact mice and in congenitally athymic nude mice." | 7.67 | Treatment of murine histoplasmosis with UK 49,858 (fluconazole). ( Ahrens, J; Graybill, JR; Palou, E, 1986) |
| "Efficacies of fluconazole, a new triazole antifungal agent, were evaluated in 11 cases of systemic mycoses (1 case each of candiduria, pulmonary cryptococcosis, pulmonary aspergillosis, pulmonary penicilliosis and suspected fungal pulmonary infection, and 3 cases each of candidemia and Candida endophthalmitis)." | 7.67 | [Fluconazole treatment of systemic mycoses]. ( Ebe, T; Hamamoto, T; Hibiya, I; Inagaki, M; Isonuma, H; Kohara, T; Matsumura, M; Mori, T; Takahashi, M; Watanabe, K, 1989) |
| "Fosfluconazole (F-FLCZ) was administered, and her condition improved." | 5.51 | Successful treatment with voriconazole combined with amphotericin B-liposome for fluconazole-resistant pulmonary cryptococcosis after renal transplantation. ( Fujioka, K; Hamasaki, Y; Kagami, S; Kinoshita, Y; Nagai, T; Shishido, S; Urushihara, M, 2019) |
| " The usefulness of fluconazole therapy, the best dosage regimen and the in vitro and in vivo correlations are discussed." | 5.31 | [Candida albicans fungemia with pulmonary localization treated with fluconazole. A case report]. ( Clavier, H; Kalfon, P; Mebtouche, B; Thomas, F, 2000) |
| "Treatment with fluconazole was effective in this case of semi-invasive aspergillosis." | 5.30 | [Successful use of fluconazole against semi-invasive--pulmonary aspergillosis]. ( Amemiya, T; Fujimura, M; Kurumaya, H; Matsuda, T; Mizuguchi, M; Nishi, K; Ohka, T; Tachibana, H, 1997) |
| "Four non-AIDS patients with pulmonary cryptococcus infection who could not tolerate amphotericin B treatment were given oral fluconazole at a dose of 600 mg once daily for 4-5 weeks followed by 400 mg once daily for 10-12 weeks resulting in cure." | 5.29 | Oral fluconazole in the treatment of pulmonary cryptococcosis in non-AIDS patients. ( Chau, CH; Lee, J; Wong, CF; Wong, PC; Yew, WW, 1996) |
| "Fluconazole is a novel triazole antifungal agent." | 5.28 | [A clinical study of fluconazole in pulmonary aspergillosis]. ( Yoneda, R, 1989) |
| "Aspergillus infection is the most frequent fungal infection associated with chronic granulomatous disease (CGD), and often results in a life-threatening situation." | 5.28 | [Effect of fluconazole on Aspergillus infection associated with chronic granulomatous disease]. ( Kawamori, J; Tsuruta, S; Yoshida, T, 1991) |
| "Fluconazole was found to be effective for the locally invasive form of PA in a healthy man." | 5.28 | Locally invasive pulmonary aspergillosis in a healthy man successfully treated with oral fluconazole. ( Fujimura, M; Matsuda, T; Myou, S; Nishi, K; Ooka, T, 1992) |
| "Fluconazole was 5-20-fold more active than ketoconazole against systemic aspergillosis and against systemic, intracranial and pulmonary cryptococcosis but was less active than amphotericin B." | 5.27 | Efficacy of fluconazole (UK-49,858) against experimental aspergillosis and cryptococcosis in mice. ( Andrews, RJ; Marriott, MS; Richardson, K; Troke, PF, 1987) |
| "In previous open-label noncomparative clinical trials, both fluconazole and itraconazole were effective therapy for progressive forms of coccidioidomycosis." | 5.09 | Comparison of oral fluconazole and itraconazole for progressive, nonmeningeal coccidioidomycosis. A randomized, double-blind trial. Mycoses Study Group. ( Catanzaro, A; Cloud, GA; Delgado, KL; Flanigan, C; Galgiani, JN; Johnson, RH; Larsen, RA; Lutz, JE; Mirels, LF; Nassar, F; Rinaldi, MG; Sharkey, PK; Singh, VR; Stevens, DA; Williams, PL, 2000) |
| "To determine the efficacy and safety of fluconazole as treatment for coccidioidomycosis." | 5.08 | Fluconazole in the treatment of chronic pulmonary and nonmeningeal disseminated coccidioidomycosis. NIAID Mycoses Study Group. ( Catanzaro, A; Chapman, SW; Cloud, G; Fierer, J; Galgiani, JN; Levine, BE; Sharkey-Mathis, PK; Stevens, DA, 1995) |
| " Owing to the poor therapeutic effects of 6-month fluconazole treatment, she underwent a second percutaneous lung biopsy and was diagnosed with pulmonary cryptococcosis coexisting with adenocarcinoma." | 4.98 | Pulmonary cryptococcosis coexisting with adenocarcinoma: a case report and review of the literature. ( Li, L; Shao, C; Zhou, J; Zhuang, L, 2018) |
| " Cryptococcus gattii occurs with greater frequency than Cryptococcus neoformans in equine pulmonic cryptococcosis and can be successfully treated with enteral fluconazole monotherapy, with disease severity determining treatment length." | 4.95 | Equine Pulmonary Cryptococcosis: A Comparative Literature Review and Evaluation of Fluconazole Monotherapy. ( Krockenberger, MB; Lester, GD; Secombe, CJ, 2017) |
| "A case of systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) associated with pulmonary cryptococcosis which was successfully treated with fluconazole (FCZ) and flucytosine (5-FC) is described." | 4.78 | [A case report--pulmonary cryptococcosis associated with systemic lupus erythematosus and review of 44 cases in Japan]. ( Kano, S; Minato, N; Saito, K; Saito, T; Saku, N; Sato, M; Suzuki, N; Takeda, A, 1993) |
| " The onset of his hypoglycemia occurred within days after starting voriconazole and subsequently fluconazole for a fungal pneumonia." | 3.88 | Unintentional sulfonylurea toxicity due to a drug-drug interaction: a case report. ( Austin, E; Gunaratne, K; Wu, PE, 2018) |
| "We present a case of pulmonary cryptococcosis presenting as wandering multiple bilateral shadows and hilar and mediastinal lymph node enlargement in which the fluconazole treatment suppressed the symptoms." | 3.79 | Pulmonary cryptococcosis presenting as wandering multiple bilateral shadows and hilar and mediastinal lymph node enlargement in the lungs. ( Cai, XP; Cao, Z; Jin, YH; Ma, MQ; Pan, JW; Ye, ZT; Zhang, N, 2013) |
| "We retrospectively analyzed the medical records and radiographic findings of 10 healthy subjects with isolated pulmonary cryptococcosis diagnosed incidentally and treated with oral fluconazole." | 3.77 | Treatment of asymptomatic pulmonary cryptococcosis in immunocompetent hosts with oral fluconazole. ( Choi, KH; Chung, CR; Han, HJ; Kim, SR; Lee, MH; Lee, YC; Min, KH; Park, SJ, 2011) |
| " We report a case of pulmonary cryptococcosis followed by pleuritis in a patient on fluconazole treatment." | 3.74 | A case of pulmonary cryptococcosis followed by pleuritis in an apparently immunocompetent patient during fluconazole treatment. ( Hayashi, T; Izumikawa, K; Kakeya, H; Kohno, S; Kurihara, S; Miyazaki, T; Miyazaki, Y; Motoshima, K; Nakamura, S; Saijo, T; Seki, M; Takazono, T; Yamamoto, Y; Yanagihara, K; Zhao, Y, 2008) |
| "The current recommended therapy for diffuse coccidioidal pneumonia involves initial treatment with amphotericin B deoxycholate or high-dose fluconazole, followed by an azole after clinical improvement." | 3.73 | Combination therapy of disseminated coccidioidomycosis with caspofungin and fluconazole. ( Cheong, HJ; Kim, JH; Kim, MJ; Kim, WJ; Park, DW; Shin, C; Sohn, JW, 2006) |
| " Coccidioidomycosis was suspected and empirically treated with fluconazole." | 3.72 | Coccidioidal pneumonia, arthritis, and soft-tissue infection after kidney transplantation. ( Blair, JE, 2004) |
| "A 49-year-old man with disseminated histoplasmosis (pulmonary and central nervous system involvement) successfully treated with ketoconazole and fluconazole combination is reported." | 3.70 | [Disseminated histoplasmosis caused by Histoplasma capsulatum with cerebral involvement occurring 13 years after the primary infection]. ( Astoul, P; Bérard, H; Boutin, C; Cho, K; Cuguillière, A; Frenay, C, 1999) |
| "We treated two cases of primary pulmonary cryptococcosis with fluconazole (FLCZ), the clinical usefulness of FLCZ was evaluated." | 3.70 | [Clinical study on fluconazole (FLCZ) in the treatment of primary pulmonary cryptococcosis]. ( Hayashi, Y; Ito, G; Takeyama, S, 1998) |
| "In order to verify whether fluconazole has a prophylactive effect against the occurrence of cryptococcosis in HIV-infected patients and to identify other factors capable of increasing or reducing the risk of this infection, we arranged a case-control study of 17 patients with cryptococcal infection." | 3.69 | Fluconazole for primary prophylaxis of AIDS-associated cryptococcosis: a case-control study. ( Ammassari, A; Antinori, A; Linzalone, A; Marasca, G; Morace, G; Murri, R, 1995) |
| "Treatment with 200 to 400 mg/day fluconazole was evaluated in 44 patients without AIDS who had cryptococcosis (19 with cryptococcal meningitis, 22 with pulmonary cryptococcosis, 3 with other cryptococcal infections)." | 3.69 | Fluconazole monotherapy for cryptococcosis in non-AIDS patients. ( Hara, K; Ikemoto, H; Ito, A; Kohno, S; Watanabe, K; Yamaguchi, H, 1996) |
| "Disseminated cryptococcosis developed in an HIV antibody positive patient who was taking fluconazole for oral candidiasis." | 3.68 | Cavitating pulmonary cryptococcosis developing in an HIV antibody patient despite prior treatment with fluconazole. ( Bell, D; Coker, RJ; Murphy, SM; Peters, BS, 1992) |
| "The triazole Bay R 3783 was compared with fluconazole, itraconazole, ketoconazole, and amphotericin B in rodent models of superficial and systemic candidiasis, meningocerebral cryptococcosis, and pulmonary aspergillosis." | 3.68 | Evaluation of Bay R 3783 in rodent models of superficial and systemic candidiasis, meningeal cryptococcosis, and pulmonary aspergillosis. ( Hector, RF; Yee, E, 1990) |
| "The triazole SCH39304 was compared with amphotericin B and fluconazole for the treatment of pulmonary aspergillosis in corticoid-immunosuppressed mice intranasally challenged with 5 x 10(6) conidia of Aspergillus fumigatus." | 3.68 | Pulmonary aspergillosis in mice: treatment with a new triazole SCH39304. ( Defaveri, J; Graybill, JR; Rinaldi, MG; Salazar, MH, 1990) |
| "The efficacy of the combination therapy of fluconazole plus flucytosine against pulmonary cryptococcosis was investigated." | 3.68 | [Pulmonary cryptococcosis treated by combination therapy of fluconazole plus flucytosine]. ( Hara, K; Kaku, M; Koga, H; Kohno, S; Maesaki, S; Mitsutake, K; Miyazaki, H; Miyazaki, T; Tanaka, K; Tomono, K, 1993) |
| " Although the patient was on prophylaxis with fluconazole and she did not respond to amphotericin B, there was an excellent response to itraconazole which allowed the transplant without any Aspergillus infection during both the transplant and the post-transplant periods." | 3.68 | [Invasive bronchopulmonary aspergillosis treated with itraconazole in a patient with acute leukemia]. ( Alvarez Blanco, A; Alvarez, C; Floristán, F; Hernández, I; Hernández, J; Ponton, J; Sarcía-Ruiz, JC, 1993) |
| "Efficacies of fluconazole, a new triazole antifungal agent, were evaluated in 11 cases of systemic mycoses (1 case each of candiduria, pulmonary cryptococcosis, pulmonary aspergillosis, pulmonary penicilliosis and suspected fungal pulmonary infection, and 3 cases each of candidemia and Candida endophthalmitis)." | 3.67 | [Fluconazole treatment of systemic mycoses]. ( Ebe, T; Hamamoto, T; Hibiya, I; Inagaki, M; Isonuma, H; Kohara, T; Matsumura, M; Mori, T; Takahashi, M; Watanabe, K, 1989) |
| "Fluconazole, a novel triazole antifungal agent, was given orally or intravenously to 10 patients with pulmonary mycosis (7 patients with primary pulmonary cryptococcosis and 3 with pulmonary aspergillosis)." | 3.67 | [Clinical efficacy of fluconazole in the patient with pulmonary mycosis]. ( Hanawa, T; Hatakenaka, R; Ikeda, S; Katsura, A; Kosaba, S; Lee, Y; Matsubara, Y; Ninomiya, K; Shiota, T; Yagi, K, 1989) |
| "Effects on pulmonary cryptococcosis and aspergillosis and the pharmacokinetics of the new antimycotic agent, fluconazole, were examined." | 3.67 | [The clinical study of fluconazole against pulmonary mycosis. Effects of fluconazole on pulmonary cryptococcosis and aspergillosis, and its pharmacokinetics in patients]. ( Nakashima, M, 1989) |
| "The clinical efficacy of fluconazole at doses of 100-400 mg daily given intravenously in the treatment of 6 cases of deep mycosis complicated with leukemia was evaluated." | 3.67 | [Clinical evaluation of fluconazole in the case of deep mycosis associated with leukemia]. ( Fukawa, H; Kodama, F; Maruta, A; Matsuzaki, M, 1989) |
| "Fluconazole was compared with ketoconazole and with amphotericin B in treatment of pulmonary histoplasmosis in immunologically intact mice and in congenitally athymic nude mice." | 3.67 | Treatment of murine histoplasmosis with UK 49,858 (fluconazole). ( Ahrens, J; Graybill, JR; Palou, E, 1986) |
| "Fluconazole was given 100-200 mg daily for 3 days to 8 months." | 2.68 | [A multiple center clinical trial on fluconazole for deep-seated fungal infections]. ( Liang, D; Xu, N; Zhang, H, 1995) |
| " The dosage and therapeutic duration were as follows: Flu 200-400 mg daily for 1-8 weeks in 34 patients with fungal infection and 150 mg as a single dose in 30 patients with fungal vaginitis; Keto 400 mg daily for 1-8 weeks in 30 patients with fungal diseases and for 5 days in 30 patients with fungal vaginitis." | 2.68 | [Fluconazole versus ketoconazole in systemic fungal infection: a double-blind randomized study]. ( Liang, D; Lu, Y; Zhang, H, 1997) |
| "Cryptococcosis has become an important infection in both immunocompromised and immunocompetent hosts." | 2.66 | Cryptococcosis. ( Baddley, JW; Zavala, S, 2020) |
| "Pulmonary Cryptococcosis is a common fungal infection mainly caused by Cryptococcus neoformans/C." | 2.66 | Pulmonary cryptococcosis coexisting with central type lung cancer in an immuocompetent patient: a case report and literature review. ( Fang, J; Han, Y; Hu, H; Qiu, X; Wang, L; Xia, R; Yao, K; Zhang, W, 2020) |
| "Coccidioidomycosis is uncommon." | 2.46 | [Pulmonary coccidioidomycosis:a case report and review of the literature]. ( Chen, L; Huang, M; Xie, WP; Zhang, ZH; Zhu, Q; Zong, F, 2010) |
| "Cryptococcosis is an important opportunistic fungal infection, especially in the immunocompromised patient." | 2.45 | Cryptococcal lung disease. ( Baddley, JW; Shirley, RM, 2009) |
| "Amphotericin B has a broad spectrum and has remained the drug of choice for these life threatening invasive fungal infections." | 2.41 | [Choice and use of antifungal drugs]. ( Dupont, B, 2001) |
| "Fluconazole is an alternative treatment especially in Cushing's disease patients with cryptococcal pneumonia." | 1.56 | Fluconazole for Hypercortisolism in Cushing's Disease: A Case Report and Literature Review. ( Cai, F; Liang, W; Wang, Y; Wu, Q; Zhao, Y, 2020) |
| "Fluconazole was administered and the computed tomography findings improved." | 1.56 | Pulmonary Cryptococcosis in a Nurse Initially Suspected of Having Pulmonary Tuberculosis. ( Ikeda, H; Kasai, H; Ogawa, H; Shinozaki, T; Urushibara, T, 2020) |
| "Fosfluconazole (F-FLCZ) was administered, and her condition improved." | 1.51 | Successful treatment with voriconazole combined with amphotericin B-liposome for fluconazole-resistant pulmonary cryptococcosis after renal transplantation. ( Fujioka, K; Hamasaki, Y; Kagami, S; Kinoshita, Y; Nagai, T; Shishido, S; Urushihara, M, 2019) |
| "Coccidioidomycosis is a fungal infection caused by Coccidioides immitis or Coccidioides posadasii." | 1.48 | Coccidioidomycosis: first cases reported in Pernambuco, Brazil. ( Antunes, A; Araújo, PSR; Arraes, LC; Lima Neto, RG; Marsden, A; Oliveira, MI; Padilha, CE; Souza Junior, VR; Vieira, R, 2018) |
| "Fluconazole was the initial, antifungal agent used." | 1.43 | Coccidioidomycosis in infants: A retrospective case series. ( Dabrowski, L; Graciano, AL; Kuzmic, B; Lee, JM; Tablizo, MA, 2016) |
| "The incidence of coccidioidomycosis is increasing, and published pediatric experience is limited." | 1.43 | Coccidioidomycosis: Experience From a Children's Hospital in an Area of Endemicity. ( Dimitrova, D; Ross, L, 2016) |
| "Our unique case presentation illustrates subcorneal pustular dermatosis as a reactive eruption owing to primary pulmonary coccidioidomycosis." | 1.42 | Subcorneal pustular dermatosis associated with Coccidioides immitis. ( Chambers, CJ; Chang, S; Fung, MA; Iyengar, S; Sharon, VR, 2015) |
| "Coccidioidomycosis is a fungal infection caused by the Coccidioides species, which is endemic in the deserts of the southwestern region of the United States, northern Mexico, and in some areas of Central and South America." | 1.40 | An imported case of acute pulmonary coccidioidomycosis in an Italian traveller. ( Antinori, A; Bellagamba, R; Corpolongo, A; Ghirga, P; Giancola, ML; Mencarini, P; Nicastri, E; Oliva, A; Pane, S; Tommasi, C, 2014) |
| " Long-term administration of oral fluconazole was well accepted and effective at treating the multifocal C." | 1.39 | Multifocal Cryptococcus neoformans var. neoforms: infection, treatment, and monitoring by serial computed tomography in a Schmidt's red-tailed guenon (Cercopithecus ascanius schmidti). ( Adkesson, MJ; Colegrove, KM; Delaney, MA; Langan, JN; Muhlbauer, MC; Nevitt, BN; Rubin, DA, 2013) |
| "Coccidioidomycosis is an endemic disease of the western hemisphere." | 1.38 | Pulmonary coccidiomycosis in New Delhi, India. ( Aggarwal, PK; Basu, AK; Khanna, S; Oberoi, JK; Verma, K; Wattal, C, 2012) |
| "A case of allergic bronchopulmonary mycosis caused by Aspergillus fumigatus and Candida albicans in a 48 year old man was discussed." | 1.38 | A patient with allergic bronchopulmonary mycosis caused by Aspergillus fumigatus and Candida albicans. ( Datau, EA, 2012) |
| "Treatment with fluconazole led to a complete recovery." | 1.38 | An unusual cause of a pulmonary opacity in a visitor to the UK. ( Atkin, CM; Downie, BA; Dubrey, SW; Rosser, G, 2012) |
| "Therefore, when eosinophilia is seen in a CBC, it can provide an important clue to the correct diagnosis." | 1.37 | Peripheral blood eosinophilia as a clue to the diagnosis of an occult Coccidioides infection. ( Kim, AS; Simons, CM; Stratton, CW, 2011) |
| "Only disseminated histoplasmosis is recognized as causing a different reaction which consists of ingestion of organisms by macrophages without granuloma formation." | 1.36 | Biopsy findings in acute pulmonary histoplasmosis: unusual histologic features in 4 cases mimicking lymphomatoid granulomatosis. ( Katzenstein, AL; Mukhopadhyay, S, 2010) |
| "Primary cutaneous coccidioidomycosis is rare." | 1.36 | Disseminated cutaneous coccidioidomycosis masquerading as lupus pernio. ( Lambiase, MC; Newlon, HR, 2010) |
| "Coccidioidomycosis is a fungal infection endemic to south-west USA, north Mexico and parts of Central and South America." | 1.36 | Primary pulmonary coccidioidomycosis in China. ( Huang, H; Lan, F; Tong, YZ; Xiong, SD; Xiong, WN; Xu, YJ, 2010) |
| "Fluconazole (37." | 1.36 | Cutaneous cryptococcosis in solid organ transplant recipients. ( Alexander, BD; Del Busto, R; Dowdy, LA; Dromer, F; Fisher, RA; Forrest, GN; Garcia-Diaz, J; Gupta, KL; House, AA; Houston, SH; Humar, A; Huprikar, S; Husain, S; John, GT; Johnson, LB; Kalil, AC; Klintmalm, GB; Limaye, AP; Lortholary, O; Lyon, GM; Morris, MI; Muñoz, P; Orloff, SL; Pruett, TL; Pursell, K; Razonable, RR; Sifri, CD; Singh, N; Somani, J; Stosor, V; Sun, HY; Wagener, MM; Wray, D, 2010) |
| "Pulmonary cryptococcosis is an unusual fungal infection that is most often found in AIDS or in organ transplant recipients." | 1.35 | [Cavitary pneumonia in an AIDS patient with cryptococcosis]. ( Arechavala, A; Corti, M; Negroni, R; Palmieri, O; Semorile, K; Trione, N, 2008) |
| "Fluconazole was given to 17 paitents, intraconazole was given to 21 patients, and intraconazole to the other 9 patients after they had no effect with fluconazole." | 1.35 | [Clinical features and treatment of invasive fungal infection in 47 patients with hematological malignancies]. ( Chen, SP; Shu, YG; Xu, YJ; Zhu, Y, 2008) |
| "Male genitourinary coccidioidomycosis is rare but it should be considered in the differential diagnosis of patients with exposure to the endemic area who present with prostatitis or epididymitis." | 1.33 | Coccidioidomycosis of the male genital tract. ( Andrews, PE; Blair, JE; Sohail, MR, 2005) |
| "Sweet syndrome (acute febrile neutrophilic dermatosis) may arise in association with a variety of underlying systemic diseases." | 1.33 | Sweet syndrome (acute febrile neutrophilic dermatosis) associated with pulmonary coccidioidomycosis. ( DiCaudo, DJ; Lim, KK; Mengden, SJ; Ortiz, KJ, 2005) |
| "Mucormycosis was diagnosed in the neutropenic state following allogeneic hematopoietic cell transplantation (n=3) or intense chemotherapy (n=3)." | 1.33 | Mucormycoses in patients with hematologic malignancies: an emerging fungal infection. ( Bethge, WA; Einsele, H; Hebart, H; Horger, M; Kanz, L; Kröber, SM; Schmalzing, M; Schumacher, U; Stuhler, G, 2005) |
| "We report a 33-year-old woman with systemic lupus erythematosus undergoing immunotherapy infected with combined invasive pulmonary aspergillosis and pulmonary cryptococcosis diagnosed by video-assisted thoracic surgery lung biopsy and she was successfully treated as a result of early diagnosis and treatment." | 1.33 | Invasive pulmonary aspergillosis and pulmonary cryptococcosis really coexist in immunocompromised host. ( Chiang, PC; Huang, CC; Huang, SF; Lee, CH; Lin, CM; Liu, HP; Tsai, YH, 2006) |
| "We report a 74-year-old woman with cervical cancer who developed pulmonary cryptococcosis which presented as a solitary focal ground-glass opacity (GGO) on high-resolution computed tomography (HRCT)." | 1.32 | Pulmonary cryptococcosis with a solitary focal ground-glass opacity on high-resolution computed tomography. ( Fukatsu, E; Hasegawa, Y; Ikeda, T; Maruyama, K; Nara, Y; Niimi, T; Okamoto, M; Sato, M; Shimokata, K; Takagi, Y, 2004) |
| "Fluconazole was the antifungal agent most frequently used, both in infected and colonized patients." | 1.32 | [Indications for antifungal treatment in intensive care unit patients]. ( Alvarez-Lerma, F; Bermejo, B; Cerdá, E; León, C; Olaechea, P; Palomar, M, 2004) |
| " The usefulness of fluconazole therapy, the best dosage regimen and the in vitro and in vivo correlations are discussed." | 1.31 | [Candida albicans fungemia with pulmonary localization treated with fluconazole. A case report]. ( Clavier, H; Kalfon, P; Mebtouche, B; Thomas, F, 2000) |
| "Fluconazole has been prescribed in 7 patients as a permanent suppressive therapy and should be continued indefinitely." | 1.30 | [Pulmonary cryptococcosis during HIV infection. 15 cases]. ( Balloul, E; Cahite, I; Caubarrère, I; Couderc, LJ; Molina, JM; Saimot, AG; Wolff, M, 1997) |
| "Treatment with fluconazole was effective in this case of semi-invasive aspergillosis." | 1.30 | [Successful use of fluconazole against semi-invasive--pulmonary aspergillosis]. ( Amemiya, T; Fujimura, M; Kurumaya, H; Matsuda, T; Mizuguchi, M; Nishi, K; Ohka, T; Tachibana, H, 1997) |
| "After this treatment, pneumonia deteriorated." | 1.29 | [Treatment of severe pneumonia due to methicillin-resistant Staphylococcus aureus (MRSA) and Candida krusei with granulocyte colony-stimulating factor (G-CSF): a case report]. ( Maezawa, H; Nakazawa, Y; Saito, A; Sakai, O; Sakamoto, M; Shiba, K; Shindou, N; Yoshida, M; Yoshikawa, K, 1993) |
| "Cryptococcus neoformans infection was diagnosed from bronchoalveolar lavage bronchoscopy." | 1.29 | Miliary pulmonary cryptococcosis in a patient with the acquired immunodeficiency syndrome. ( Douketis, JD; Kesten, S, 1993) |
| "Fluconazole is considered to be a potent, safe antifungal agent for the treatment of suspected fungal infections associated with hematological diseases." | 1.29 | [Clinical efficacy of fluconazole against fungal infections in hematological diseases]. ( Asahara, F; Hisano, S; Kawasaki, C; Kimura, N; Morioka, E; Nagano, M; Nakashima, H; Okumura, M; Suzumiya, J; Uchida, T; Yoshida, T, 1996) |
| "Four non-AIDS patients with pulmonary cryptococcus infection who could not tolerate amphotericin B treatment were given oral fluconazole at a dose of 600 mg once daily for 4-5 weeks followed by 400 mg once daily for 10-12 weeks resulting in cure." | 1.29 | Oral fluconazole in the treatment of pulmonary cryptococcosis in non-AIDS patients. ( Chau, CH; Lee, J; Wong, CF; Wong, PC; Yew, WW, 1996) |
| "Amphotericin B (AMPH) was injected daily in 5 patients, Fulconazol (FCZ) in 2 patients, and both in the remaining patient." | 1.29 | [Percutaneous intracavitary treatment of pulmonary aspergilloma-clinical efficacy and prognosis]. ( Furuse, F; Hara, N; Ikeda, T; Inoue, H; Kotoh, H; Nakanishi, Y; Yatsunami, J, 1994) |
| "Case 2 was a boy with candida pneumonitis." | 1.29 | [Fluconazole therapy for pediatric patients with severe candidal infections]. ( Hisakawa, H; Kurashige, T; Misaki, Y; Morita, H; Okada, T; Sinohara, M; Tomoda, T; Wakiguchi, H; Watanabe, S, 1994) |
| "Pulmonary cryptococcosis has been considered as a disease associated with depressed immune function of the host." | 1.29 | [Clinical evaluation of diagnosis and treatment in three cases of primary pulmonary cryptococcosis]. ( Fukai, Y; Kashiwabara, K; Nakamura, H; Semba, H, 1993) |
| "We present here three AIDS patients with disseminated cryptococcal infection and lung involvement." | 1.28 | [Pulmonary cryptococcosis in AIDS]. ( Ariza, J; Carratalà, J; Martos, A; Mascaró, J; Podzamczer, D; Santín, M, 1992) |
| "Fluconazole was found to be effective for the locally invasive form of PA in a healthy man." | 1.28 | Locally invasive pulmonary aspergillosis in a healthy man successfully treated with oral fluconazole. ( Fujimura, M; Matsuda, T; Myou, S; Nishi, K; Ooka, T, 1992) |
| "Fluconazole was markedly effective against septicemia due to Candida and oral candidiasis accompanied with lingual ulcer in spite of seriousness of these underlying disease." | 1.28 | [Clinical evaluation of fluconazole in patients with mycotic infection]. ( Adachi, M; Ikeda, H; Kawanishi, M; Matsushima, T; Nakamura, J; Tanabe, J; Tano, Y; Tomizawa, S, 1989) |
| "Fluconazole is a novel triazole antifungal agent." | 1.28 | [A clinical study of fluconazole in pulmonary aspergillosis]. ( Yoneda, R, 1989) |
| "Aspergillus infection is the most frequent fungal infection associated with chronic granulomatous disease (CGD), and often results in a life-threatening situation." | 1.28 | [Effect of fluconazole on Aspergillus infection associated with chronic granulomatous disease]. ( Kawamori, J; Tsuruta, S; Yoshida, T, 1991) |
| "Fluconazole was 5-20-fold more active than ketoconazole against systemic aspergillosis and against systemic, intracranial and pulmonary cryptococcosis but was less active than amphotericin B." | 1.27 | Efficacy of fluconazole (UK-49,858) against experimental aspergillosis and cryptococcosis in mice. ( Andrews, RJ; Marriott, MS; Richardson, K; Troke, PF, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (4.32) | 18.7374 |
| 1990's | 66 (35.68) | 18.2507 |
| 2000's | 56 (30.27) | 29.6817 |
| 2010's | 46 (24.86) | 24.3611 |
| 2020's | 9 (4.86) | 2.80 |
| Authors | Studies |
|---|---|
| Enger, K | 3 |
| Tonnar, X | 3 |
| Kotter, E | 3 |
| Bertz, H | 3 |
| Zhang, Y | 1 |
| Zhang, SX | 1 |
| Trivedi, J | 1 |
| Toll, AD | 1 |
| Brahmer, J | 1 |
| Hales, R | 1 |
| Bonerigo, S | 1 |
| Zeng, M | 1 |
| Li, H | 1 |
| Yung, RC | 1 |
| Guzman, KJ | 1 |
| Suthar, LA | 1 |
| Phan, NQ | 1 |
| Tirado, M | 1 |
| Moeckel, SMC | 1 |
| Sunderkoetter, C | 1 |
| Metze, D | 1 |
| Goerge, T | 1 |
| Ogawa, H | 1 |
| Urushibara, T | 1 |
| Kasai, H | 1 |
| Ikeda, H | 2 |
| Shinozaki, T | 1 |
| Zavala, S | 1 |
| Baddley, JW | 2 |
| Zhou, B | 1 |
| She, J | 1 |
| Yang, L | 1 |
| Zhu, B | 1 |
| Sadamatsu, H | 1 |
| Takahashi, K | 1 |
| Tashiro, H | 1 |
| Ogusu, S | 1 |
| Haraguchi, T | 1 |
| Nakashima, C | 1 |
| Nakamura, T | 2 |
| Sueoka-Aragane, N | 1 |
| Yao, K | 1 |
| Qiu, X | 1 |
| Hu, H | 1 |
| Han, Y | 1 |
| Zhang, W | 2 |
| Xia, R | 1 |
| Wang, L | 1 |
| Fang, J | 1 |
| Yang, G | 1 |
| Chen, J | 1 |
| Ye, J | 1 |
| Yao, Y | 1 |
| Pan, Z | 1 |
| Zhao, Y | 2 |
| Liang, W | 1 |
| Cai, F | 1 |
| Wu, Q | 1 |
| Wang, Y | 2 |
| Johnson, K | 1 |
| Dhamrah, U | 1 |
| Amin, A | 1 |
| Masci, J | 1 |
| Li, YH | 1 |
| Sun, P | 1 |
| Guo, JC | 1 |
| Chao, J | 1 |
| Culpepper, KS | 1 |
| Kurtzman, DJB | 1 |
| Qu, J | 1 |
| Wang, X | 1 |
| Liu, Y | 1 |
| Lv, X | 1 |
| Gunaratne, K | 1 |
| Austin, E | 1 |
| Wu, PE | 1 |
| Manning, MA | 1 |
| Kuo, PH | 1 |
| Yeager, AM | 1 |
| Li, L | 1 |
| Zhuang, L | 1 |
| Zhou, J | 1 |
| Shao, C | 1 |
| Araújo, PSR | 1 |
| Souza Junior, VR | 1 |
| Padilha, CE | 1 |
| Oliveira, MI | 1 |
| Arraes, LC | 1 |
| Vieira, R | 1 |
| Antunes, A | 1 |
| Lima Neto, RG | 1 |
| Marsden, A | 1 |
| Fujioka, K | 1 |
| Nagai, T | 1 |
| Kinoshita, Y | 1 |
| Urushihara, M | 1 |
| Hamasaki, Y | 1 |
| Shishido, S | 1 |
| Kagami, S | 1 |
| Spoor, MS | 1 |
| Zigioli, VA | 1 |
| Jacocks, KA | 1 |
| Nevitt, BN | 1 |
| Langan, JN | 1 |
| Adkesson, MJ | 1 |
| Delaney, MA | 1 |
| Rubin, DA | 1 |
| Muhlbauer, MC | 1 |
| Colegrove, KM | 1 |
| Pan, JW | 1 |
| Zhang, N | 1 |
| Jin, YH | 1 |
| Ye, ZT | 1 |
| Ma, MQ | 1 |
| Cai, XP | 1 |
| Cao, Z | 1 |
| Shu, S | 1 |
| Xu, S | 1 |
| Ye, F | 1 |
| Zhou, H | 1 |
| Fang, F | 1 |
| Corpolongo, A | 1 |
| Giancola, ML | 1 |
| Ghirga, P | 1 |
| Oliva, A | 1 |
| Mencarini, P | 1 |
| Pane, S | 1 |
| Bellagamba, R | 1 |
| Tommasi, C | 1 |
| Antinori, A | 2 |
| Nicastri, E | 1 |
| Rodriguez-Morales, AJ | 1 |
| Jiménez-Canizales, CE | 1 |
| Mondragón-Cardona, A | 1 |
| Taype-Rondán, A | 1 |
| Vargas-Gandica, JA | 1 |
| Gupta, V | 1 |
| Karnik, ND | 1 |
| Agrawal, D | 1 |
| Tiwari, DK | 1 |
| Makino, Y | 1 |
| Nishiyama, O | 2 |
| Sano, H | 1 |
| Iwanaga, T | 1 |
| Higashimoto, Y | 1 |
| Kume, H | 1 |
| Tohda, Y | 1 |
| Brischetto, A | 1 |
| Kidd, S | 1 |
| Baird, R | 1 |
| Tüfekçi, Ö | 1 |
| Yılmaz Bengoa, Ş | 1 |
| Demir Yenigürbüz, F | 1 |
| Şimşek, E | 1 |
| Karapınar, TH | 1 |
| İrken, G | 1 |
| Ören, H | 1 |
| Iyengar, S | 1 |
| Chambers, CJ | 1 |
| Chang, S | 1 |
| Fung, MA | 1 |
| Sharon, VR | 1 |
| Lee, JM | 1 |
| Graciano, AL | 1 |
| Dabrowski, L | 1 |
| Kuzmic, B | 1 |
| Tablizo, MA | 1 |
| Dimitrova, D | 1 |
| Ross, L | 1 |
| Secombe, CJ | 1 |
| Lester, GD | 1 |
| Krockenberger, MB | 1 |
| Pawar, S | 1 |
| Ganakumar, V | 1 |
| Jha, S | 1 |
| Ragesh, R | 1 |
| Ray, A | 1 |
| Kakkar, A | 1 |
| Sharma, MC | 1 |
| Sharma, SK | 1 |
| Liu, X | 1 |
| Jia, W | 1 |
| Huang, S | 1 |
| Sun, G | 1 |
| Nishikawa, H | 1 |
| Fukuda, Y | 1 |
| Mitsuyama, J | 1 |
| Tashiro, M | 1 |
| Tanaka, A | 1 |
| Takazono, T | 2 |
| Saijo, T | 2 |
| Yamamoto, K | 1 |
| Nakamura, S | 3 |
| Imamura, Y | 1 |
| Miyazaki, T | 3 |
| Kakeya, H | 3 |
| Yamamoto, Y | 3 |
| Yanagihara, K | 3 |
| Mukae, H | 1 |
| Kohno, S | 6 |
| Izumikawa, K | 3 |
| Kojima, T | 1 |
| Takase, K | 1 |
| Nakaya, J | 1 |
| Igarashi, K | 1 |
| Yamaguchi, W | 1 |
| Kaizaki, Y | 1 |
| Nakaya, T | 1 |
| Salemis, NS | 1 |
| Tsolakis, K | 1 |
| Aloizos, S | 1 |
| Tsohataridis, E | 1 |
| Seki, M | 2 |
| Miyazaki, Y | 2 |
| Montineri, A | 1 |
| Iacobello, C | 1 |
| Larocca, L | 1 |
| La Rosa, R | 1 |
| Nigro, L | 1 |
| Fatuzzo, F | 1 |
| Wu, B | 1 |
| Liu, H | 1 |
| Huang, J | 1 |
| Zhang, T | 1 |
| Motoshima, K | 1 |
| Kurihara, S | 1 |
| Hayashi, T | 1 |
| How, SH | 1 |
| Kuan, YC | 1 |
| Ng, TH | 1 |
| Ramachandram, K | 1 |
| Fauzi, AR | 1 |
| Lahmiti, S | 1 |
| Baki, S | 1 |
| Shirley, RM | 1 |
| Guevara-Campos, J | 1 |
| González-Guevara, L | 1 |
| Urbéz-Cano, J | 1 |
| Fermín, S | 1 |
| Sun, HY | 1 |
| Alexander, BD | 1 |
| Lortholary, O | 1 |
| Dromer, F | 1 |
| Forrest, GN | 1 |
| Lyon, GM | 1 |
| Somani, J | 1 |
| Gupta, KL | 1 |
| Del Busto, R | 1 |
| Pruett, TL | 1 |
| Sifri, CD | 1 |
| Limaye, AP | 1 |
| John, GT | 1 |
| Klintmalm, GB | 1 |
| Pursell, K | 1 |
| Stosor, V | 1 |
| Morris, MI | 1 |
| Dowdy, LA | 1 |
| Muñoz, P | 1 |
| Kalil, AC | 1 |
| Garcia-Diaz, J | 1 |
| Orloff, SL | 1 |
| House, AA | 1 |
| Houston, SH | 1 |
| Wray, D | 1 |
| Huprikar, S | 1 |
| Johnson, LB | 1 |
| Humar, A | 1 |
| Razonable, RR | 1 |
| Fisher, RA | 1 |
| Husain, S | 1 |
| Wagener, MM | 1 |
| Singh, N | 1 |
| Mukhopadhyay, S | 1 |
| Katzenstein, AL | 1 |
| Lan, F | 1 |
| Tong, YZ | 1 |
| Huang, H | 1 |
| Xiong, WN | 1 |
| Xu, YJ | 2 |
| Xiong, SD | 1 |
| Zong, F | 1 |
| Xie, WP | 1 |
| Huang, M | 1 |
| Zhu, Q | 1 |
| Chen, L | 1 |
| Zhang, ZH | 1 |
| Newlon, HR | 1 |
| Lambiase, MC | 1 |
| Simons, CM | 1 |
| Stratton, CW | 1 |
| Kim, AS | 1 |
| Karino, T | 1 |
| Osaki, K | 1 |
| Kanamori, K | 1 |
| Yahata, T | 1 |
| Choi, KH | 1 |
| Park, SJ | 1 |
| Min, KH | 1 |
| Kim, SR | 1 |
| Lee, MH | 2 |
| Chung, CR | 1 |
| Han, HJ | 1 |
| Lee, YC | 2 |
| Matsumoto, M | 1 |
| Kita, Y | 1 |
| Gocho, T | 1 |
| Wakiyama, S | 1 |
| Sakamoto, T | 1 |
| Iida, T | 1 |
| Misawa, T | 1 |
| Ishida, Y | 1 |
| Yanaga, K | 1 |
| El Ouazzani, H | 1 |
| Souhi, H | 1 |
| Achachi, L | 1 |
| Alaziz, AS | 1 |
| El Ftouh, MT | 1 |
| Achir, A | 1 |
| El Fassy Fihry, MT | 1 |
| Gill, PK | 1 |
| Gill, JS | 1 |
| Chandrashekar, UK | 1 |
| Acharya, V | 1 |
| Varghese, GK | 1 |
| Rao, L | 1 |
| Kresch, ZA | 1 |
| Espinosa-Heidmann, D | 1 |
| Harper, T | 1 |
| Jamie Miller, G | 1 |
| White, FN | 1 |
| Zedek, DC | 1 |
| Collins, DL | 1 |
| Boswell, JS | 1 |
| Downie, BA | 1 |
| Rosser, G | 1 |
| Atkin, CM | 1 |
| Dubrey, SW | 1 |
| Oberoi, JK | 1 |
| Wattal, C | 1 |
| Aggarwal, PK | 1 |
| Khanna, S | 1 |
| Basu, AK | 1 |
| Verma, K | 1 |
| Datau, EA | 1 |
| Turaka, K | 1 |
| Gordon, AJ | 1 |
| Patel, S | 1 |
| Bryan, JS | 1 |
| Kwong, HM | 1 |
| Dugel, PU | 1 |
| Arogyasami, RM | 1 |
| Noro, R | 1 |
| Saito, T | 2 |
| Suzuki, J | 1 |
| Ueno, T | 1 |
| Watanabe, K | 5 |
| Aoki, H | 1 |
| Hayashihara, K | 1 |
| Nara, M | 1 |
| Kudo, S | 1 |
| Gil, E | 1 |
| Durán, MT | 1 |
| Rodríguez-Tudela, JL | 1 |
| Cuenca-Estrella, M | 1 |
| Cartelle, M | 1 |
| Molina, F | 1 |
| Guerrero, A | 1 |
| Pan, AH | 1 |
| Janner, D | 1 |
| Tsuchiyama, T | 1 |
| Naitoh, H | 1 |
| Kouzuma, K | 1 |
| Motoyama, H | 1 |
| Kinuwaki, E | 1 |
| Sato, M | 2 |
| Okamoto, M | 1 |
| Takagi, Y | 1 |
| Ikeda, T | 2 |
| Niimi, T | 1 |
| Fukatsu, E | 1 |
| Maruyama, K | 1 |
| Nara, Y | 1 |
| Shimokata, K | 1 |
| Hasegawa, Y | 1 |
| Lee, YA | 1 |
| Kim, HJ | 1 |
| Lee, TW | 1 |
| Kim, MJ | 2 |
| Lee, JH | 1 |
| Ihm, CG | 1 |
| Höhl, R | 1 |
| Tanigawa, M | 1 |
| Kimura, M | 1 |
| Ichioka, M | 1 |
| Saito, K | 2 |
| Chen, YH | 1 |
| Yao, WZ | 1 |
| Wang, JL | 1 |
| Alvarez-Lerma, F | 1 |
| Palomar, M | 1 |
| León, C | 1 |
| Olaechea, P | 1 |
| Cerdá, E | 1 |
| Bermejo, B | 1 |
| Blair, JE | 2 |
| Yoshida, M | 3 |
| Wang, CY | 1 |
| Jerng, JS | 1 |
| Ko, JC | 1 |
| Lin, MF | 1 |
| Hsiao, CH | 1 |
| Lee, LN | 1 |
| Hsueh, PR | 1 |
| Kuo, SH | 1 |
| Iwasaki, Y | 1 |
| Tominaga, M | 1 |
| Kuroki, S | 1 |
| Kato, O | 1 |
| Huang, CJ | 1 |
| Yang, MC | 1 |
| Ueng, SH | 1 |
| Sohail, MR | 1 |
| Andrews, PE | 1 |
| DiCaudo, DJ | 1 |
| Ortiz, KJ | 1 |
| Mengden, SJ | 1 |
| Lim, KK | 1 |
| Bethge, WA | 1 |
| Schmalzing, M | 1 |
| Stuhler, G | 1 |
| Schumacher, U | 1 |
| Kröber, SM | 1 |
| Horger, M | 1 |
| Einsele, H | 1 |
| Kanz, L | 1 |
| Hebart, H | 1 |
| Lin, CM | 1 |
| Tsai, YH | 1 |
| Huang, CC | 1 |
| Lee, CH | 1 |
| Chiang, PC | 1 |
| Huang, SF | 1 |
| Liu, HP | 1 |
| Romano, A | 1 |
| Giordano, S | 1 |
| Di Carlo, P | 1 |
| Abbagnato, L | 1 |
| Sapuppo, F | 1 |
| Lazzaro, G | 1 |
| Tetamo, R | 1 |
| Titone, L | 1 |
| Shen, Q | 1 |
| Song, XM | 1 |
| Xu, XP | 1 |
| Wang, JM | 1 |
| Park, DW | 1 |
| Sohn, JW | 1 |
| Cheong, HJ | 1 |
| Kim, WJ | 1 |
| Kim, JH | 1 |
| Shin, C | 1 |
| Goldman, DL | 1 |
| Davis, J | 1 |
| Bommarito, F | 1 |
| Shao, X | 1 |
| Casadevall, A | 1 |
| Benetatos, L | 1 |
| Hatzimichael, E | 1 |
| Vassou, A | 1 |
| Bourantas, KL | 1 |
| Voigt, C | 1 |
| Lill, H | 1 |
| Sakamoto, K | 1 |
| Aso, H | 1 |
| Yokoyama, T | 1 |
| Kato, K | 1 |
| Kimura, T | 1 |
| Kondoh, Y | 1 |
| Taniguchi, H | 1 |
| Shimamoto, A | 1 |
| Takao, M | 1 |
| Shomura, S | 1 |
| Tarukawa, T | 1 |
| Shimpo, H | 1 |
| Zhu, Y | 1 |
| Chen, SP | 1 |
| Shu, YG | 1 |
| Corti, M | 1 |
| Trione, N | 1 |
| Semorile, K | 1 |
| Palmieri, O | 1 |
| Negroni, R | 2 |
| Arechavala, A | 1 |
| Maiolo, E | 1 |
| Arechavala, AI | 1 |
| Bianchi, MH | 1 |
| Santiso, G | 1 |
| L'Her, P | 1 |
| Savuth, C | 1 |
| Than, T | 1 |
| San, KK | 1 |
| Vuthea, KS | 1 |
| Leang, S | 1 |
| Sophouen, N | 1 |
| Arborio, M | 1 |
| Coppola, S | 1 |
| Angarano, G | 1 |
| Montagna, MT | 1 |
| Congedo, P | 1 |
| Monno, L | 1 |
| Bellisario, A | 1 |
| Pastore, G | 1 |
| Yoshikawa, K | 1 |
| Maezawa, H | 1 |
| Shindou, N | 1 |
| Sakamoto, M | 1 |
| Nakazawa, Y | 1 |
| Shiba, K | 1 |
| Saito, A | 1 |
| Sakai, O | 1 |
| Onizuka, O | 2 |
| Kawano, M | 1 |
| Takikawa, S | 1 |
| Sugihara, R | 1 |
| Ando, H | 1 |
| Emmons, WW | 1 |
| Luchsinger, S | 1 |
| Miller, L | 1 |
| Shibuya, Y | 1 |
| Kitamura, S | 1 |
| Wan, P | 1 |
| Yan, QH | 1 |
| Gao, C | 1 |
| Catanzaro, A | 3 |
| Galgiani, JN | 2 |
| Levine, BE | 1 |
| Sharkey-Mathis, PK | 1 |
| Fierer, J | 2 |
| Stevens, DA | 3 |
| Chapman, SW | 1 |
| Cloud, G | 1 |
| Joly, V | 1 |
| Shirai, T | 1 |
| Taniguchi, M | 1 |
| Imokawa, S | 1 |
| Sugiura, W | 1 |
| Sato, A | 1 |
| Genma, H | 1 |
| Takamoto, M | 1 |
| Ishibashi, T | 1 |
| Shinoda, A | 1 |
| Nakanishi, Y | 3 |
| Nomoto, K | 1 |
| Miyahara, T | 1 |
| Oizumi, K | 2 |
| Ichikawa, Y | 2 |
| Pahls, S | 1 |
| Schaffner, A | 1 |
| Igarashi, T | 1 |
| Nakagawa, A | 1 |
| Yoshida, Y | 1 |
| Nishiyama, K | 1 |
| Abe, S | 1 |
| Furuse, F | 1 |
| Kotoh, H | 1 |
| Inoue, H | 1 |
| Yatsunami, J | 2 |
| Hara, N | 2 |
| Tanaka, K | 1 |
| Maesaki, S | 2 |
| Mitsutake, K | 1 |
| Miyazaki, H | 1 |
| Tomono, K | 1 |
| Kaku, M | 2 |
| Koga, H | 3 |
| Hara, K | 2 |
| Sarcía-Ruiz, JC | 1 |
| Alvarez, C | 1 |
| Floristán, F | 1 |
| Hernández, I | 1 |
| Hernández, J | 1 |
| Alvarez Blanco, A | 1 |
| Ponton, J | 1 |
| Martino, P | 1 |
| Girmenia, C | 1 |
| Wakiguchi, H | 1 |
| Hisakawa, H | 1 |
| Sinohara, M | 1 |
| Watanabe, S | 2 |
| Okada, T | 1 |
| Misaki, Y | 1 |
| Tomoda, T | 1 |
| Morita, H | 1 |
| Kurashige, T | 1 |
| Kono, S | 1 |
| Nakamura, H | 1 |
| Kashiwabara, K | 1 |
| Fukai, Y | 1 |
| Semba, H | 1 |
| Bozzette, SA | 1 |
| Yamada, H | 2 |
| Saku, N | 1 |
| Takeda, A | 1 |
| Suzuki, N | 1 |
| Minato, N | 1 |
| Kano, S | 1 |
| Douketis, JD | 1 |
| Kesten, S | 1 |
| Ammassari, A | 1 |
| Linzalone, A | 1 |
| Murri, R | 1 |
| Marasca, G | 1 |
| Morace, G | 1 |
| Guillaume, MP | 1 |
| De Prez, C | 1 |
| Cogan, E | 1 |
| Klein, NC | 1 |
| Cunha, BA | 1 |
| Sugar, AM | 3 |
| Liu, XP | 2 |
| Liang, D | 2 |
| Xu, N | 1 |
| Zhang, H | 2 |
| Morioka, E | 1 |
| Asahara, F | 1 |
| Nagano, M | 1 |
| Kawasaki, C | 1 |
| Yoshida, T | 2 |
| Uchida, T | 1 |
| Nakashima, H | 1 |
| Suzumiya, J | 1 |
| Kimura, N | 1 |
| Hisano, S | 1 |
| Okumura, M | 1 |
| Yew, WW | 1 |
| Wong, PC | 1 |
| Wong, CF | 1 |
| Lee, J | 1 |
| Chau, CH | 1 |
| Hata, K | 1 |
| Kimura, J | 1 |
| Miki, H | 1 |
| Toyosawa, T | 1 |
| Moriyama, M | 1 |
| Katsu, K | 1 |
| Wakamatsu, K | 1 |
| Nomoto, Y | 1 |
| Kawasaki, M | 1 |
| Takayama, K | 1 |
| Tsuruta, N | 1 |
| Hashimoto, S | 1 |
| Pickles, RW | 1 |
| Pacey, DE | 1 |
| Muir, DB | 1 |
| Merrell, WH | 1 |
| Yamaguchi, H | 1 |
| Ikemoto, H | 2 |
| Ito, A | 1 |
| Kawayama, T | 1 |
| Sawa, A | 1 |
| Sueyasu, Y | 1 |
| Arikawa, K | 1 |
| Shiraishi, T | 1 |
| Mirels, LF | 2 |
| Hirano, K | 1 |
| Saitoh, T | 1 |
| Kadono, K | 1 |
| Oose, H | 1 |
| Hasegawa, S | 1 |
| Katz, BJ | 1 |
| Scott, WE | 1 |
| Folk, JC | 1 |
| Mizuguchi, M | 1 |
| Nishi, K | 2 |
| Amemiya, T | 1 |
| Tachibana, H | 1 |
| Ohka, T | 1 |
| Kurumaya, H | 1 |
| Fujimura, M | 2 |
| Matsuda, T | 2 |
| Balloul, E | 1 |
| Couderc, LJ | 1 |
| Molina, JM | 1 |
| Cahite, I | 1 |
| Wolff, M | 1 |
| Saimot, AG | 1 |
| Caubarrère, I | 1 |
| Cunningham, ET | 1 |
| Seiff, SR | 1 |
| Berger, TG | 1 |
| Lizotte, PE | 1 |
| Howes, EL | 1 |
| Horton, JC | 1 |
| Ferré, A | 1 |
| Domingo, P | 1 |
| Alonso, C | 1 |
| Franquet, T | 1 |
| Gurguí, M | 1 |
| Verger, G | 1 |
| Hayashi, Y | 1 |
| Ito, G | 1 |
| Takeyama, S | 1 |
| Lu, Y | 1 |
| Yamaguchi, S | 1 |
| Mishio, M | 1 |
| Okuda, Y | 1 |
| Kitajima, T | 1 |
| Weber, C | 1 |
| Maas, R | 1 |
| Steiner, P | 1 |
| Kramer, J | 1 |
| Bumann, D | 1 |
| Zander, AR | 1 |
| Bücheler, E | 1 |
| Bérard, H | 1 |
| Astoul, P | 1 |
| Frenay, C | 1 |
| Cuguillière, A | 1 |
| Cho, K | 1 |
| Boutin, C | 1 |
| Arsura, EL | 1 |
| Kilgore, WB | 1 |
| Chew, GT | 1 |
| Robinson, BW | 1 |
| Thomas, F | 1 |
| Mebtouche, B | 1 |
| Clavier, H | 1 |
| Kalfon, P | 1 |
| Hamacher, J | 1 |
| Spiliopoulos, A | 1 |
| Kurt, AM | 1 |
| Nicod, LP | 1 |
| Zander, DS | 1 |
| Cicale, MJ | 1 |
| Mergo, P | 1 |
| Anndo, T | 1 |
| Kawana, A | 1 |
| Núñez, M | 1 |
| Peacock, JE | 1 |
| Chin, R | 1 |
| Powderly, WG | 1 |
| Cloud, GA | 1 |
| Johnson, RH | 1 |
| Williams, PL | 1 |
| Nassar, F | 1 |
| Lutz, JE | 1 |
| Sharkey, PK | 1 |
| Singh, VR | 1 |
| Larsen, RA | 1 |
| Delgado, KL | 1 |
| Flanigan, C | 1 |
| Rinaldi, MG | 2 |
| Schreiber, J | 1 |
| Göring, HD | 1 |
| Rosahl, W | 1 |
| Strüben, C | 1 |
| Lakotta, W | 1 |
| Amthor, M | 1 |
| Takahashi, T | 1 |
| Hitani, A | 1 |
| Iwamoto, A | 1 |
| Hood, SV | 1 |
| Moore, CB | 1 |
| Denning, DW | 1 |
| Dupont, B | 1 |
| Krupova, Y | 1 |
| Mistrik, M | 1 |
| Bojtarova, E | 1 |
| Sejnova, D | 1 |
| Ilavska, I | 1 |
| Krcmery, V | 1 |
| Malani, PN | 1 |
| Bleicher, JJ | 1 |
| Kauffman, CA | 1 |
| Davenport, DS | 1 |
| Tripathy, U | 1 |
| Yung, GL | 1 |
| Kriett, JM | 1 |
| Thistlethwaite, PA | 1 |
| Kapelanski, DP | 1 |
| Jamieson, SW | 1 |
| Odom, T | 1 |
| Anderson, JG | 1 |
| Martos, A | 1 |
| Mascaró, J | 1 |
| Santín, M | 1 |
| Ariza, J | 1 |
| Carratalà, J | 1 |
| Podzamczer, D | 1 |
| Myou, S | 1 |
| Ooka, T | 1 |
| Schaberg, T | 1 |
| Lode, H | 1 |
| Harms, K | 1 |
| Herting, E | 1 |
| Schiffmann, JH | 1 |
| Speer, CP | 1 |
| Nishii, K | 1 |
| Kodani, T | 1 |
| Uji, H | 1 |
| Moritani, Y | 1 |
| Ohnoshi, T | 1 |
| Hiraki, S | 1 |
| Ueoka, H | 1 |
| Numata, T | 1 |
| Maeda, T | 1 |
| Kimura, I | 1 |
| Georgiev, VS | 1 |
| Coker, RJ | 1 |
| Bell, D | 1 |
| Peters, BS | 1 |
| Murphy, SM | 1 |
| Yoshimatsu, T | 1 |
| Matsumoto, T | 1 |
| Tsuda, T | 1 |
| Kawamori, J | 1 |
| Tsuruta, S | 1 |
| Hector, RF | 1 |
| Yee, E | 1 |
| Defaveri, J | 1 |
| Salazar, MH | 1 |
| Graybill, JR | 2 |
| Quist, P | 1 |
| Tauris, P | 1 |
| Friedman, PJ | 1 |
| Picard, M | 1 |
| Noble, L | 1 |
| Maruta, A | 1 |
| Matsuzaki, M | 1 |
| Fukawa, H | 1 |
| Kodama, F | 1 |
| Nakashima, M | 1 |
| Lee, Y | 1 |
| Shiota, T | 1 |
| Ikeda, S | 1 |
| Katsura, A | 1 |
| Hanawa, T | 1 |
| Yagi, K | 1 |
| Kosaba, S | 1 |
| Hatakenaka, R | 1 |
| Matsubara, Y | 1 |
| Ninomiya, K | 1 |
| Matsushima, T | 1 |
| Tomizawa, S | 1 |
| Nakamura, J | 1 |
| Adachi, M | 1 |
| Kawanishi, M | 1 |
| Tanabe, J | 1 |
| Tano, Y | 1 |
| Yoneda, R | 1 |
| Mori, T | 1 |
| Matsumura, M | 1 |
| Ebe, T | 1 |
| Takahashi, M | 1 |
| Kohara, T | 1 |
| Inagaki, M | 1 |
| Isonuma, H | 1 |
| Hibiya, I | 1 |
| Hamamoto, T | 1 |
| Palou, E | 1 |
| Ahrens, J | 1 |
| Troke, PF | 1 |
| Andrews, RJ | 1 |
| Marriott, MS | 1 |
| Richardson, K | 1 |
29 reviews available for fluconazole and Fungal Lung Diseases
| Article | Year |
|---|---|
Pleural fluid secondary to pulmonary cryptococcal infection: a case report and review of the literature.
Topics: Administration, Oral; Aged; Antifungal Agents; Carcinoma, Non-Small-Cell Lung; Cryptococcosis; Crypt | 2019 |
Cryptococcosis.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Cryptococcosis; Fluconazol | 2020 |
Coexistent pulmonary cryptococcal infection and pulmonary sarcoidosis: a case report and literature review.
Topics: Adult; Biopsy; Bronchoalveolar Lavage Fluid; Bronchoscopy; Cryptococcosis; Cryptococcus neoformans; | 2020 |
Pulmonary cryptococcosis coexisting with central type lung cancer in an immuocompetent patient: a case report and literature review.
Topics: Aged; Comorbidity; Cryptococcosis; Fluconazole; Humans; Immunocompetence; Lung Diseases, Fungal; Lun | 2020 |
Possible environmental exposure-associated pulmonary cryptococcosis in a patient with rheumatoid arthritis: a case report and literature review.
Topics: Aged; Arthritis, Rheumatoid; Cryptococcosis; Environmental Exposure; Female; Fluconazole; Humans; Lu | 2020 |
RAPIDLY PROGRESSIVE PULMONARY CRYPTOCOCCOSIS WITH CAVITATION IN AN IMMUNOCOMPETENT WOMAN: A CASE REPORT AND LITERATURE REVIEW.
Topics: Adult; Antifungal Agents; Cryptococcosis; Female; Fluconazole; Humans; Immunocompetence; Lung Diseas | 2017 |
Pulmonary cryptococcosis coexisting with adenocarcinoma: a case report and review of the literature.
Topics: Adenocarcinoma; Antifungal Agents; Asian People; Comorbidity; Cryptococcosis; Female; Fluconazole; H | 2018 |
Equine Pulmonary Cryptococcosis: A Comparative Literature Review and Evaluation of Fluconazole Monotherapy.
Topics: Animals; Antifungal Agents; Cryptococcosis; Cryptococcus; Female; Fluconazole; Horse Diseases; Horse | 2017 |
Pulmonary cryptococcosis in late pregnancy and review of published literature.
Topics: Adult; Antifungal Agents; Cryptococcosis; Diagnosis, Differential; Female; Fluconazole; Humans; Lung | 2009 |
Cryptococcal lung disease.
Topics: Antifungal Agents; Cryptococcosis; Fluconazole; Humans; Immunocompromised Host; Lung Diseases, Funga | 2009 |
[Pulmonary coccidioidomycosis:a case report and review of the literature].
Topics: Aged; Antifungal Agents; Coccidioides; Coccidioidomycosis; Fluconazole; Humans; Lung Diseases, Funga | 2010 |
First report of Cryptococcus albidus--induced disseminated cryptococcosis in a renal transplant recipient.
Topics: Adult; Antifungal Agents; Cryptococcosis; Cyclosporine; Diagnosis, Differential; Fluconazole; Graft | 2004 |
[New therapeutical options for pulmonary fungal infections in non-neutropenic ICU-patients].
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Fluconazole; Fungi; Humans; Intensive | 2003 |
[Diagnosis and treatment of pulmonary fungal infection in intensive care unit].
Topics: Antifungal Agents; Candida; Cross Infection; Fluconazole; Humans; Intensive Care Units; Lung Disease | 2004 |
[Guidelines for the management of deep mycosis in neutropenic patients].
Topics: Amphotericin B; Aspergillosis; Candidiasis; Echinocandins; Fluconazole; Humans; Lipopeptides; Lipopr | 2004 |
[Role of chemoprophylaxis in the prevention of invasive aspergillosis].
Topics: Aerosols; Amphotericin B; Aspergillosis; Drug Therapy, Combination; Female; Fluconazole; Flucytosine | 1994 |
Aspergillus fumigatus pneumonia in neutropenic patients receiving fluconazole for infection due to Candida species: is amphotericin B combined with fluconazole the appropriate answer?
Topics: Amphotericin B; Aspergillosis; Aspergillus fumigatus; Drug Interactions; Drug Therapy, Combination; | 1994 |
Diagnosis and treatment of invasive fungal infections in cancer patients.
Topics: Amphotericin B; Aspergillosis; Fluconazole; Humans; Itraconazole; Lung Diseases, Fungal; Mycoses; Ne | 1993 |
The management of cryptococcal disease in patients with AIDS.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Central Nervous System Dis | 1993 |
[A case report--pulmonary cryptococcosis associated with systemic lupus erythematosus and review of 44 cases in Japan].
Topics: Arthritis, Rheumatoid; Cryptococcosis; Drug Therapy, Combination; Female; Fluconazole; Flucytosine; | 1993 |
Subacute mitochondrial liver disease in a patient with AIDS: possible relationship to prolonged fluconazole administration.
Topics: Acquired Immunodeficiency Syndrome; Acute Disease; Adult; AIDS-Related Opportunistic Infections; Ant | 1996 |
New antifungal drugs for pulmonary mycoses.
Topics: Antifungal Agents; Fluconazole; Humans; Itraconazole; Ketoconazole; Lung Diseases, Fungal | 1996 |
[Conversion of chronic necrotizing pulmonary aspergillosis to invasive pulmonary aspergillosis, and successful treatment with fluconazole].
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Antifungal Agents; Arthritis, Rheumatoid; Aspergi | 1997 |
Pulmonary cryptococcosis in the immunocompetent host. Therapy with oral fluconazole: a report of four cases and a review of the literature.
Topics: Administration, Oral; Aged; Antibodies, Fungal; Antifungal Agents; Antigens, Fungal; Biopsy, Needle; | 2000 |
Current approach to the acute management of cryptococcal infections.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; CD4 Lymphocyte Count; Cryp | 2000 |
[Choice and use of antifungal drugs].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Fluconazole; Flucytosine; Humans; Itr | 2001 |
Disseminated Dactylaria constricta infection in a renal transplant recipient.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Diagnosis, Differential; Fatal Outcome; Female; Fluc | 2001 |
[Therapy of pulmonary mycoses].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillosis, Allergic Bronchopulmonary; Blastomy | 1992 |
Treatment and developmental therapeutics in aspergillosis. 2. Azoles and other antifungal drugs.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillosis, Allergic Bronchopulmonary; Azoles; Clotrim | 1992 |
7 trials available for fluconazole and Fungal Lung Diseases
| Article | Year |
|---|---|
Fluconazole in the treatment of chronic pulmonary and nonmeningeal disseminated coccidioidomycosis. NIAID Mycoses Study Group.
Topics: Adult; Aged; Aged, 80 and over; Chronic Disease; Coccidioidomycosis; Fluconazole; Humans; Lung Disea | 1995 |
[Usefulness of percutaneous instillation of antifungal agents for pulmonary aspergilloma].
Topics: Aged; Aged, 80 and over; Antifungal Agents; Aspergillosis; Female; Fluconazole; Humans; Instillation | 1995 |
[A clinical study on fluconazole against pulmonary mycosis associated with respiratory diseases].
Topics: Adult; Aged; Aspergillosis; Candidiasis; Cryptococcosis; Female; Fluconazole; Humans; Lung Diseases, | 1994 |
[A multiple center clinical trial on fluconazole for deep-seated fungal infections].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillosis; Candidiasis; Child; Fe | 1995 |
[Fluconazole versus ketoconazole in systemic fungal infection: a double-blind randomized study].
Topics: Adolescent; Adult; Aged; Antifungal Agents; Candidiasis, Oral; Double-Blind Method; Female; Fluconaz | 1997 |
Pre-emptive therapy with azoles in lung transplant patients. Geneva Lung Transplantation Group.
Topics: Adult; Antifungal Agents; Child; Female; Fluconazole; Humans; Itraconazole; Lung Diseases, Fungal; L | 1999 |
Comparison of oral fluconazole and itraconazole for progressive, nonmeningeal coccidioidomycosis. A randomized, double-blind trial. Mycoses Study Group.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Algorithms; Antifungal Agents; Bon | 2000 |
149 other studies available for fluconazole and Fungal Lung Diseases
| Article | Year |
|---|---|
Sequential low-dose CT thorax scans to determine invasive pulmonary fungal infection incidence after allogeneic hematopoietic cell transplantation.
Topics: Antifungal Agents; Fluconazole; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Invasive | 2023 |
Sequential low-dose CT thorax scans to determine invasive pulmonary fungal infection incidence after allogeneic hematopoietic cell transplantation.
Topics: Antifungal Agents; Fluconazole; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Invasive | 2023 |
Sequential low-dose CT thorax scans to determine invasive pulmonary fungal infection incidence after allogeneic hematopoietic cell transplantation.
Topics: Antifungal Agents; Fluconazole; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Invasive | 2023 |
Sequential low-dose CT thorax scans to determine invasive pulmonary fungal infection incidence after allogeneic hematopoietic cell transplantation.
Topics: Antifungal Agents; Fluconazole; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Invasive | 2023 |
Axonal Polyneuropathy in a Man Treated for Pulmonary Cocci: A Case of Acute Intermittent Porphyria.
Topics: Aged; Antifungal Agents; Coccidioidomycosis; Fluconazole; Humans; Lung Diseases, Fungal; Male; Polyn | 2019 |
Cutaneous and pulmonary cryptococcosis in an immunocompetent patient.
Topics: Amphotericin B; Antifungal Agents; Cryptococcosis; Dermatomycoses; Diagnosis, Differential; Drug The | 2019 |
Pulmonary Cryptococcosis in a Nurse Initially Suspected of Having Pulmonary Tuberculosis.
Topics: Adult; Bronchoalveolar Lavage Fluid; Bronchoscopy; Cryptococcosis; Delayed Diagnosis; Female; Flucon | 2020 |
A rare case of Trichosporon mycotoxinivorans and Cryptococcus neoformans co-infection in lung.
Topics: Aged; Antifungal Agents; Biopsy; Bronchoalveolar Lavage Fluid; Coinfection; Cryptococcosis; Cryptoco | 2020 |
Fluconazole for Hypercortisolism in Cushing's Disease: A Case Report and Literature Review.
Topics: Antifungal Agents; Brain; Cryptococcosis; Cryptococcus neoformans; Cushing Syndrome; Female; Flucona | 2020 |
Case Report: A Great Mimicker of Neoplasm: Pulmonary Cryptococcosis in an Immunocompetent Host After High-Altitude Descent.
Topics: Aged, 80 and over; Altitude; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Diagnosis, | 2021 |
Clinical Analysis of Diabetic Combined Pulmonary Mucormycosis.
Topics: Adult; Amphotericin B; Antifungal Agents; Diabetes Complications; Diabetes Mellitus; Female; Flucona | 2017 |
Follicular papules and pustules in a patient with pulmonary symptoms.
Topics: Aged; Amphotericin B; Antifungal Agents; Coccidioidomycosis; Fatal Outcome; Fluconazole; Folliculiti | 2018 |
Unintentional sulfonylurea toxicity due to a drug-drug interaction: a case report.
Topics: Antifungal Agents; Diabetes Mellitus, Type 2; Drug Interactions; Fluconazole; Gliclazide; Humans; Hy | 2018 |
Disseminated coccidioidomycosis masquerading as recurrent lymphoma.
Topics: Antifungal Agents; Coccidioides; Coccidioidomycosis; Diagnosis, Differential; Female; Fluconazole; G | 2018 |
Coccidioidomycosis: first cases reported in Pernambuco, Brazil.
Topics: Adult; Aged; Animals; Antifungal Agents; Armadillos; Coccidioidomycosis; Fluconazole; Humans; Lung D | 2018 |
Successful treatment with voriconazole combined with amphotericin B-liposome for fluconazole-resistant pulmonary cryptococcosis after renal transplantation.
Topics: Amphotericin B; Antifungal Agents; Antigens, Fungal; Combined Modality Therapy; Cryptococcosis; Cryp | 2019 |
What is your diagnosis? Bronchoalveolar wash fluid from a dog.
Topics: Animals; Antifungal Agents; Bronchoalveolar Lavage Fluid; Dog Diseases; Dogs; Female; Fluconazole; L | 2019 |
Multifocal Cryptococcus neoformans var. neoforms: infection, treatment, and monitoring by serial computed tomography in a Schmidt's red-tailed guenon (Cercopithecus ascanius schmidti).
Topics: Animals; Antifungal Agents; Cercopithecus; Cryptococcosis; Cryptococcus neoformans; Female; Fluconaz | 2013 |
Pulmonary cryptococcosis presenting as wandering multiple bilateral shadows and hilar and mediastinal lymph node enlargement in the lungs.
Topics: Adult; Antifungal Agents; Cryptococcosis; Fluconazole; Humans; Lung Diseases, Fungal; Lymph Nodes; M | 2013 |
[Case 136th--intermittent fever for over 20 days and coughing for 2 days].
Topics: Amphotericin B; Antifungal Agents; Biomarkers; Child; Cough; Cryptococcosis; Fever; Fluconazole; Hum | 2014 |
An imported case of acute pulmonary coccidioidomycosis in an Italian traveller.
Topics: Administration, Intravenous; Administration, Oral; Antifungal Agents; Coccidioides; Coccidioidomycos | 2014 |
So, if I travel to "Venezuela", can I get coccidioidomycosis?
Topics: Antifungal Agents; Coccidioides; Coccidioidomycosis; Fluconazole; Humans; Lung Diseases, Fungal; Mal | 2014 |
A case of lung mass: a common association between uncommon diseases.
Topics: Adult; Amphotericin B; Antifungal Agents; Chest Pain; Cough; Cryptococcosis; Drug Therapy, Combinati | 2014 |
Cavitary pulmonary cryptococcosis with an Aspergillus fungus ball.
Topics: Adalimumab; Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Antifungal Agents; Bronchos | 2014 |
First reported Australian case of Cladophilophora arxii: features consistent with possible primary pulmonary chromoblastomycosis.
Topics: Aged; Antifungal Agents; Ascomycota; Australia; Chromoblastomycosis; Fluconazole; Humans; Lung; Lung | 2015 |
Management of Invasive Fungal Infections in Pediatric Acute Leukemia and the Appropriate Time for Restarting Chemotherapy.
Topics: Adolescent; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Prescho | 2015 |
Subcorneal pustular dermatosis associated with Coccidioides immitis.
Topics: Adolescent; Antifungal Agents; Back Pain; California; Coccidioides; Coccidioidomycosis; Delayed Diag | 2015 |
Coccidioidomycosis in infants: A retrospective case series.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Coccidioidomycosis; Cough; Diagnosis, Differential; | 2016 |
Coccidioidomycosis: Experience From a Children's Hospital in an Area of Endemicity.
Topics: Adolescent; Antifungal Agents; Child; Child, Preschool; Coccidioidomycosis; Complement Fixation Test | 2016 |
Pulmonary Cryptococcoma Masquerading as Lung Cancer.
Topics: Amphotericin B; Antifungal Agents; Chest Pain; Cough; Cryptococcosis; Cryptococcus neoformans; Fluco | 2016 |
A case of pulmonary cryptococcosis with large pericardial effusion diagnosed using cervical lymph node biopsy.
Topics: Adult; Antifungal Agents; Biopsy, Needle; Cryptococcosis; Female; Fluconazole; Humans; Immunohistoch | 2018 |
In vitro and in vivo antifungal activities of T-2307, a novel arylamidine, against Cryptococcus gattii: an emerging fungal pathogen.
Topics: Amidines; Amphotericin B; Animals; Antifungal Agents; Brain; Cryptococcosis; Cryptococcus gattii; Cr | 2017 |
[Case of pulmonary coccidioidomycosis presented with multiple infiltrative opacities].
Topics: Antifungal Agents; beta-Glucans; Biomarkers; California; Coccidioidomycosis; Eosinophils; Fluconazol | 2008 |
Multiple septic complications of disseminated candidiasis following anorectal sepsis in a non-immunocompromised patient.
Topics: Aged, 80 and over; Antifungal Agents; Anus Diseases; Candida albicans; Candidiasis; Epididymitis; Fl | 2008 |
[Saccharomyces cerevisiae fungemia associated with multifocal pneumonia in a patient with alcohol-related hepatic cirrhosis].
Topics: Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Fluconazole; Humans; Immunocompromised | 2008 |
Pulmonary cryptococcosis in non-AIDS patients.
Topics: Adolescent; Adult; Amphotericin B; Antifungal Agents; Cryptococcosis; Drug Therapy, Combination; Fem | 2009 |
A case of pulmonary cryptococcosis followed by pleuritis in an apparently immunocompetent patient during fluconazole treatment.
Topics: Adult; Base Sequence; Cryptococcosis; Cryptococcus neoformans; Fluconazole; Humans; Immunocompromise | 2008 |
An unusual cause of haemoptysis and headache: cryptococcosis.
Topics: Adult; Amphotericin B; Antifungal Agents; Cryptococcosis; Diagnosis, Differential; Fluconazole; Head | 2008 |
Thoracic blastomycosis from Morocco.
Topics: Blastomycosis; Clothing; Commerce; Fluconazole; Humans; Lung Diseases, Fungal; Male; Morocco; Occupa | 2009 |
[Cryptococcus neoformans meningoencephalitis in immunocompetent schoolchildren].
Topics: Amphotericin B; Animals; Animals, Domestic; Antifungal Agents; Blindness; Cerebrospinal Fluid; Child | 2009 |
Cutaneous cryptococcosis in solid organ transplant recipients.
Topics: Antifungal Agents; Central Nervous System Fungal Infections; Cohort Studies; Cryptococcosis; Cryptoc | 2010 |
Biopsy findings in acute pulmonary histoplasmosis: unusual histologic features in 4 cases mimicking lymphomatoid granulomatosis.
Topics: Adult; Antifungal Agents; Biopsy; Diagnosis, Differential; Female; Fluconazole; Granuloma; Histiocyt | 2010 |
Primary pulmonary coccidioidomycosis in China.
Topics: Adolescent; Amphotericin B; Asian People; Coccidioides; Coccidioidomycosis; Cough; Fluconazole; Huma | 2010 |
Disseminated cutaneous coccidioidomycosis masquerading as lupus pernio.
Topics: Antifungal Agents; Coccidioidomycosis; Dermatomycoses; Fluconazole; Follow-Up Studies; Humans; Lung | 2010 |
Peripheral blood eosinophilia as a clue to the diagnosis of an occult Coccidioides infection.
Topics: Aged; Antifungal Agents; Antigens, Fungal; Coccidioides; Coccidioidomycosis; DNA, Fungal; Eosinophil | 2011 |
[Case of pulmonary cryptococcosis which developed in a patient receiving abatacept therapy for rheumatoid arthritis].
Topics: Abatacept; Antifungal Agents; Antigens, Fungal; Antirheumatic Agents; Arthritis, Rheumatoid; Biomark | 2010 |
Treatment of asymptomatic pulmonary cryptococcosis in immunocompetent hosts with oral fluconazole.
Topics: Administration, Oral; Aged; Antifungal Agents; Antigens, Fungal; Asymptomatic Infections; Cryptococc | 2011 |
Successful liver transplantation from a living donor with asymptomatic pulmonary cryptococcosis.
Topics: Antifungal Agents; Asymptomatic Diseases; Cryptococcosis; Cryptococcus neoformans; Drug Administrati | 2011 |
[Pseudotumor of pulmonary cryptococcosis in the immunocompetent].
Topics: Adult; Antifungal Agents; Biopsy; Biopsy, Needle; Bronchoscopy; Combined Modality Therapy; Cryptococ | 2011 |
Blastoschizomyces capitatus pneumonia in an immuno-competent female.
Topics: Aged; Antifungal Agents; Diagnosis, Differential; Female; Fluconazole; Humans; Immunocompetence; Lun | 2011 |
An unusual presentation of pulmonary cryptococcosis with co-existing disseminated tuberculosis in an AIDS patient.
Topics: Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Antitubercular Agents; Cryptococcos | 2012 |
Disseminated Cryptococcus with ocular cryptococcoma in a human immunodeficiency virus-negative patient.
Topics: Amphotericin B; Anemia, Hemolytic, Autoimmune; Antifungal Agents; Cryptococcosis; Cryptococcus; Drug | 2012 |
Granuloma annulare arising in association with pulmonary coccidioidomycosis.
Topics: Antifungal Agents; Coccidioidomycosis; Female; Fluconazole; Granuloma Annulare; Humans; Immunoglobul | 2012 |
An unusual cause of a pulmonary opacity in a visitor to the UK.
Topics: Antifungal Agents; Arizona; Coccidioides; Coccidioidomycosis; Cough; Fluconazole; Humans; Lung; Lung | 2012 |
Pulmonary coccidiomycosis in New Delhi, India.
Topics: Aged; Antifungal Agents; Bronchoalveolar Lavage Fluid; Coccidioides; Coccidioidomycosis; Fluconazole | 2012 |
A patient with allergic bronchopulmonary mycosis caused by Aspergillus fumigatus and Candida albicans.
Topics: Ambroxol; Anti-Bacterial Agents; Antifungal Agents; Aspergillus fumigatus; Bronchodilator Agents; Bu | 2012 |
Diagnostic and therapeutic challenges.
Topics: Administration, Oral; Antibodies, Fungal; Antifungal Agents; Choroid Diseases; Coccidioides; Coccidi | 2013 |
[A case of secondary pulmonary cryptococcosis showing various radiographic changes during its natural course without antifungal treatment].
Topics: Antifungal Agents; Antigens, Fungal; Biomarkers; Cryptococcosis; Diagnosis, Differential; Fluconazol | 2002 |
[Pseudozyma sp.: colonizer of the respiratory tract in critical patients].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Critical Care; Female | 2003 |
Lung mass in a sixteen-year-old young man.
Topics: Adolescent; Antigens, Fungal; Biopsy, Needle; Cryptococcosis; Cryptococcus neoformans; Diagnosis, Di | 2003 |
[A case of rapidly progressing pulmonary aspergillosis presenting various forms of shadow].
Topics: Aged; Aspergillosis; Aspergillus; Chronic Disease; Disease Progression; Female; Fluconazole; Humans; | 2003 |
Pulmonary cryptococcosis with a solitary focal ground-glass opacity on high-resolution computed tomography.
Topics: Aged; Antifungal Agents; Cryptococcosis; Disease Progression; Female; Fluconazole; Humans; Lung Dise | 2004 |
[A case of secondary pulmonary cryptococcosis complicating diabetes mellitus].
Topics: Aged; Antifungal Agents; Antigens, Fungal; Cryptococcosis; Cryptococcus neoformans; Diabetes Complic | 2004 |
[Indications for antifungal treatment in intensive care unit patients].
Topics: Antifungal Agents; APACHE; Candidiasis; Comorbidity; Critical Care; Cross Infection; Fluconazole; Fu | 2004 |
Coccidioidal pneumonia, arthritis, and soft-tissue infection after kidney transplantation.
Topics: Antifungal Agents; Arthritis, Infectious; Coccidioides; Coccidioidomycosis; Fluconazole; Humans; Kid | 2004 |
Disseminated coccidioidomycosis.
Topics: Aged; Antifungal Agents; Coccidioides; Coccidioidomycosis; Drug Resistance, Fungal; Fluconazole; Fun | 2005 |
[Case of primary pulmonary cryptococcosis accompanied by severe back pain].
Topics: Administration, Oral; Adult; Antifungal Agents; Antigens, Fungal; Back Pain; Biomarkers; Cryptococco | 2005 |
Large cryptococcoma mimicking lung cancer in an HIV-negative, type 2 diabetic patient.
Topics: Aged; Antifungal Agents; Biopsy, Needle; Cryptococcosis; Diabetes Mellitus, Type 2; Diagnosis, Diffe | 2005 |
Coccidioidomycosis of the male genital tract.
Topics: Aged; Aged, 80 and over; Antifungal Agents; Coccidioides; Coccidioidomycosis; Diagnosis, Differentia | 2005 |
Sweet syndrome (acute febrile neutrophilic dermatosis) associated with pulmonary coccidioidomycosis.
Topics: Administration, Oral; Administration, Topical; Aged; Biopsy, Needle; Clobetasol; Coccidioidomycosis; | 2005 |
Mucormycoses in patients with hematologic malignancies: an emerging fungal infection.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Antineoplastic Agents; Communicable Diseases, Emergi | 2005 |
Invasive pulmonary aspergillosis and pulmonary cryptococcosis really coexist in immunocompromised host.
Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Cryptococcosis; Female; Fluconazole; Humans | 2006 |
[Pulmonary infection caused by Blastoschizomices capitatus].
Topics: Aged; Amphotericin B; Antifungal Agents; Blastomyces; Blastomycosis; Fatal Outcome; Female; Fluconaz | 2005 |
[Pulmonary fungal infection in malignant hematological diseases: an analysis of 14 cases].
Topics: Adolescent; Adult; Aged; Antifungal Agents; Aspergillosis; Candidiasis; Female; Fluconazole; Hematol | 2005 |
Combination therapy of disseminated coccidioidomycosis with caspofungin and fluconazole.
Topics: Adult; Antifungal Agents; Caspofungin; Coccidioidomycosis; Drug Therapy, Combination; Echinocandins; | 2006 |
Enhanced allergic inflammation and airway responsiveness in rats with chronic Cryptococcus neoformans infection: potential role for fungal pulmonary infection in the pathogenesis of asthma.
Topics: Animals; Antifungal Agents; Asthma; Bronchoalveolar Lavage Fluid; Chronic Disease; Cryptococcosis; C | 2006 |
Cryptococcus lung infection complicating fludarabine treatment in a chronic lymphocytic leukemia patient.
Topics: Aged; Antifungal Agents; Antineoplastic Agents; Cryptococcosis; Fluconazole; Humans; Leukemia, Lymph | 2007 |
[Candida albicans induced spondylodiscitis of the cervical spine of a polytraumatized patient].
Topics: Adult; Antifungal Agents; Candidiasis; Cervical Vertebrae; Combined Modality Therapy; Discitis; Epid | 2006 |
[Primary pulmonary cryptococcosis: a case series of 9 patients].
Topics: Adult; Aged; Antifungal Agents; Cryptococcosis; Female; Fluconazole; Humans; Immunity, Cellular; Lun | 2007 |
Pulmonary histoplasmosis as an example of imported mycoses in Japan.
Topics: Bolivia; Fluconazole; Histoplasmosis; Humans; Japan; Lung Diseases, Fungal; Male; Middle Aged; Trave | 2007 |
[Clinical features and treatment of invasive fungal infection in 47 patients with hematological malignancies].
Topics: Adolescent; Adult; Aged; Antifungal Agents; Aspergillosis; Candidiasis; Female; Fluconazole; Hematol | 2008 |
[Cavitary pneumonia in an AIDS patient with cryptococcosis].
Topics: Adult; AIDS-Related Opportunistic Infections; Antibiotic Prophylaxis; Antifungal Agents; Antiretrovi | 2008 |
[Clinical cases in medical mycology. Case no. 32].
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Aspergillosis; Bacteremia; Bronchoalveolar | 2008 |
[Severe pulmonary and meningeal cryptococcosis in an immunocompetent Cambodian].
Topics: Cambodia; Combined Modality Therapy; Cryptococcosis; Diagnosis, Differential; Fluconazole; Humans; I | 1995 |
Efficacy of itraconazole in treating AIDS-associated infections due to Candida krusei.
Topics: Adult; AIDS-Related Opportunistic Infections; Candida; Candidiasis; Candidiasis, Oral; Dermatomycose | 1995 |
[Treatment of severe pneumonia due to methicillin-resistant Staphylococcus aureus (MRSA) and Candida krusei with granulocyte colony-stimulating factor (G-CSF): a case report].
Topics: Adult; Anti-Bacterial Agents; Antifungal Agents; Candida; Candidiasis; Drug Therapy, Combination; Fl | 1993 |
[Pharmacokinetics of transbronchially injected flconazole in pulmonary aspergillosis].
Topics: Aged; Aspergillosis; Bronchi; Epithelium; Female; Fluconazole; Humans; Injections, Intralesional; Lu | 1995 |
Progressive pulmonary cryptococcosis in a patient who is immunocompetent.
Topics: Cryptococcosis; Disease Progression; Fluconazole; Follow-Up Studies; Humans; Immunocompetence; Lung | 1995 |
[A case of primary pulmonary cryptococcosis showing infiltrative shadows in the unilateral lung field].
Topics: Aged; Amphotericin B; Cryptococcosis; Fluconazole; Humans; Lung Diseases, Fungal; Male; Miconazole; | 1994 |
[Case report of pulmonary histoplasmosis].
Topics: Adult; Fluconazole; Histoplasmosis; Humans; Lung Diseases, Fungal; Male | 1994 |
[A case of primary pulmonary cryptococcosis with increased serum carcinoembryonic antigen].
Topics: Adult; Carcinoembryonic Antigen; Cryptococcosis; Diagnosis, Differential; Fluconazole; Humans; Lung | 1994 |
[Percutaneous intracavitary treatment of pulmonary aspergilloma-clinical efficacy and prognosis].
Topics: Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Aspergillosis; Female; Fluconazol | 1994 |
[Pulmonary cryptococcosis treated by combination therapy of fluconazole plus flucytosine].
Topics: Aged; Cryptococcosis; Cryptococcus neoformans; Drug Resistance, Microbial; Drug Synergism; Drug Ther | 1993 |
[Invasive bronchopulmonary aspergillosis treated with itraconazole in a patient with acute leukemia].
Topics: Agranulocytosis; Amphotericin B; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Bone | 1993 |
[Fluconazole therapy for pediatric patients with severe candidal infections].
Topics: Adolescent; Candidiasis; Child; Esophagitis; Female; Fluconazole; Humans; Lung Diseases, Fungal; Mal | 1994 |
[Diagnosis and therapy of pulmonary mycoses].
Topics: Adolescent; Adult; Aged; Amphotericin B; Cryptococcosis; Cryptococcus neoformans; Female; Fluconazol | 1993 |
[Clinical evaluation of diagnosis and treatment in three cases of primary pulmonary cryptococcosis].
Topics: Adult; Cryptococcosis; Female; Fluconazole; Humans; Lung; Lung Diseases, Fungal; Male; Miconazole; M | 1993 |
Topical treatment of pulmonary aspergilloma by antifungals. Relationship between duration of the disease and efficacy of therapy.
Topics: Aged; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Aspergillus niger; Fe | 1993 |
Miliary pulmonary cryptococcosis in a patient with the acquired immunodeficiency syndrome.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Cryptococcosis; Cryptococcus neoforman | 1993 |
Fluconazole for primary prophylaxis of AIDS-associated cryptococcosis: a case-control study.
Topics: Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Antigens, Fungal; Case-Control Stud | 1995 |
In vitro and in vivo activities of SCH 56592 against Blastomyces dermatitidis.
Topics: Amphotericin B; Animals; Antifungal Agents; Blastomyces; Blastomycosis; Drug Evaluation, Preclinical | 1996 |
[Clinical efficacy of fluconazole against fungal infections in hematological diseases].
Topics: Adult; Antifungal Agents; Female; Fluconazole; Fungemia; Humans; Injections, Intravenous; Leukemia; | 1996 |
Oral fluconazole in the treatment of pulmonary cryptococcosis in non-AIDS patients.
Topics: Adult; Antifungal Agents; Cryptococcosis; Female; Fluconazole; Humans; Lung Diseases, Fungal; Male | 1996 |
Efficacy of ER-30346, a novel oral triazole antifungal agent, in experimental models of aspergillosis, candidiasis, and cryptococcosis.
Topics: Animals; Antifungal Agents; Aspergillosis; Brain Diseases; Candidiasis; Candidiasis, Oral; Cryptococ | 1996 |
Empyema following the percutaneous instillation of antifungal agents in patients with aspergillosis.
Topics: Aged; Amphotericin B; Antifungal Agents; Aspergillosis; Empyema; Fluconazole; Humans; Injections; Lu | 1996 |
Experience with infection by Scedosporium prolificans including apparent cure with fluconazole therapy.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Ascomycota; Fluconazole; Humans; Leg Injuries; Lung Dise | 1996 |
Fluconazole monotherapy for cryptococcosis in non-AIDS patients.
Topics: Adult; Aged; Antifungal Agents; Antigens, Fungal; Cryptococcosis; Cryptococcus neoformans; Female; F | 1996 |
[Chronic pulmonary paracoccidioidomyosis in a Japanese Adult].
Topics: Antifungal Agents; Chronic Disease; Fluconazole; Humans; Lung Diseases, Fungal; Male; Middle Aged; P | 1996 |
Update on treatment of coccidioidomycosis.
Topics: Amphotericin B; Antifungal Agents; Coccidioidomycosis; Fluconazole; Humans; Immunocompromised Host; | 1997 |
Acute histoplasmosis choroiditis in 2 immunocompetent brothers.
Topics: Acute Disease; Antibodies, Fungal; Antifungal Agents; Antigens, Fungal; Child, Preschool; Choroiditi | 1997 |
[Successful use of fluconazole against semi-invasive--pulmonary aspergillosis].
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Fluconazole; Humans; Lung Diseases, Fungal; | 1997 |
[Pulmonary cryptococcosis during HIV infection. 15 cases].
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Cryptococcosis; Flu | 1997 |
Intraocular coccidioidomycosis diagnosed by skin biopsy.
Topics: Adult; Amphotericin B; Biopsy; Bone Diseases; Brain Diseases; Chorioretinitis; Coccidioidomycosis; D | 1998 |
[Invasive pulmonary aspergillosis: a study of 33 cases].
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillosis; Cross Infection; Female; Fluconazo | 1998 |
[Clinical study on fluconazole (FLCZ) in the treatment of primary pulmonary cryptococcosis].
Topics: Adult; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Drug Resistance, Microbial; Fluco | 1998 |
[Anesthetic management for transtracheal placement of a catheter for intracavity infusion of an antifungal drug in patients with pulmonary fungus ball of aspergillosis].
Topics: Aged; Anesthesia, General; Antifungal Agents; Aspergillosis; Catheterization; Female; Fluconazole; H | 1999 |
[Importance of digital thoracic radiography in the diagnosis of pulmonary infiltrates in patients with bone marrow transplantation during aplasia].
Topics: Adult; Anemia, Aplastic; Anti-Infective Agents; Antibiotic Prophylaxis; Antifungal Agents; Bone Marr | 1999 |
[Disseminated histoplasmosis caused by Histoplasma capsulatum with cerebral involvement occurring 13 years after the primary infection].
Topics: Antifungal Agents; Brain; Brain Diseases; Central Nervous System Fungal Infections; Fluconazole; His | 1999 |
Miliary coccidioidomycosis in the immunocompetent.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Chronic Disease; Coccidioidomycosis; Diagnosis, Diff | 2000 |
Pulmonary and meningeal cryptococcosis in pulmonary alveolar proteinosis.
Topics: Adult; Antifungal Agents; Cryptococcosis; Fluconazole; Humans; Lung Diseases, Fungal; Male; Meningit | 1999 |
[Candida albicans fungemia with pulmonary localization treated with fluconazole. A case report].
Topics: Adult; Anti-Bacterial Agents; Antifungal Agents; Candidiasis; Catheterization, Central Venous; Cross | 2000 |
Combination antifungal therapy in treatment of murine pulmonary mucormycosis: roles of quinolones and azoles.
Topics: 4-Quinolones; Animals; Anti-Infective Agents; Antifungal Agents; Disease Models, Animal; Drug Therap | 2000 |
Durable cure of mucormycosis involving allograft and native lungs.
Topics: Adult; Amphotericin B; Antifungal Agents; Drug Administration Routes; Drug Therapy, Combination; Fem | 2000 |
[Two cases of pulmonary aspergillosis successfully treated with multidrug therapy].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Drug Therapy, Combination; Fluconazole; Flucytosin | 2000 |
[Four cases of pulmonary aspergilloma successfully treated with drug therapy].
Topics: Administration, Inhalation; Administration, Oral; Aged; Aged, 80 and over; Amphotericin B; Antifunga | 2000 |
Interstitial lung disease induced by endogenous Candida albicans.
Topics: Antifungal Agents; Antigens, Fungal; Candida albicans; Candidiasis; Female; Fluconazole; Humans; Imm | 2001 |
Desenitization to fluconazole in an AIDS patient.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Cryptococcosis; Desensitization, Immunolog | 2001 |
Neurospora sitophila pulmonary infection in a patient with AIDS.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Fatal Outcome; Fluconazole; Humans; Lung D | 1997 |
Liposomal nystatin (L-NYS) in therapy of pulmonary aspergillosis refractory to conventional amphotericin B in cancer patients.
Topics: Adolescent; Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Child; Female; Fluconazole; Hum | 2001 |
Donor transfer of pulmonary coccidioidomycosis in lung transplantation.
Topics: Adult; Antifungal Agents; Coccidioidomycosis; Fluconazole; Humans; Lung Diseases, Fungal; Lung Trans | 2002 |
Proliferative gingival lesion in a cat with disseminated cryptococcosis.
Topics: Animals; Antigens, Fungal; Cat Diseases; Cats; Cryptococcosis; Cryptococcus neoformans; Cyproheptadi | 2000 |
[Pulmonary cryptococcosis in AIDS].
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Cr | 1992 |
Locally invasive pulmonary aspergillosis in a healthy man successfully treated with oral fluconazole.
Topics: Administration, Oral; Aged; Aspergillosis; Fluconazole; Humans; Lung Diseases, Fungal; Male; Tomogra | 1992 |
[Candida infections in premature infants weighing less than 1,500 g. Mucocutaneous colonization and incidence of systemic infections].
Topics: Candidiasis, Chronic Mucocutaneous; Cesarean Section; Cross Infection; Cross-Sectional Studies; Drug | 1992 |
[Six cases of primary pulmonary cryptococcosis].
Topics: Adult; Aged; Biopsy; Bronchoscopy; Cryptococcosis; Female; Fluconazole; Flucytosine; Humans; Lung Di | 1992 |
Cavitating pulmonary cryptococcosis developing in an HIV antibody patient despite prior treatment with fluconazole.
Topics: Adult; Candidiasis, Oral; Cryptococcosis; Fluconazole; HIV Seropositivity; Humans; Lung Diseases, Fu | 1992 |
[Percutaneous instillation of fluconazole in the treatment of pulmonary aspergilloma].
Topics: Administration, Cutaneous; Aged; Aspergillosis; Female; Fluconazole; Humans; Injections, Intralesion | 1991 |
[Effect of fluconazole on Aspergillus infection associated with chronic granulomatous disease].
Topics: Aspergillosis; Aspergillus fumigatus; Child, Preschool; Fluconazole; Granulomatous Disease, Chronic; | 1991 |
[Drug therapy of intractable mycoses].
Topics: Administration, Oral; Amphotericin B; Aspergillosis; Candidiasis; Cryptococcosis; Fluconazole; Flucy | 1990 |
Evaluation of Bay R 3783 in rodent models of superficial and systemic candidiasis, meningeal cryptococcosis, and pulmonary aspergillosis.
Topics: Administration, Oral; Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Crypto | 1990 |
Pulmonary aspergillosis in mice: treatment with a new triazole SCH39304.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Female; Fluconazol | 1990 |
Short-term curative treatment of Aspergillus fumigatus pneumonia with fluconazole.
Topics: Aged; Aspergillosis; Aspergillus fumigatus; Female; Fluconazole; Humans; Lung Diseases, Fungal; Pneu | 1990 |
Fluconazole in the treatment of persistent coccidioidomycosis.
Topics: Adult; Aged; Aged, 80 and over; Coccidioides; Coccidioidomycosis; Dermatomycoses; Female; Fluconazol | 1990 |
Treatment of murine pulmonary blastomycosis with SCH 39304, a new triazole antifungal agent.
Topics: Amphotericin B; Animals; Antifungal Agents; Blastomycosis; Fluconazole; Lung; Lung Diseases, Fungal; | 1990 |
[Clinical evaluation of fluconazole in the case of deep mycosis associated with leukemia].
Topics: Acute Disease; Adolescent; Adult; Aged; Antifungal Agents; Candidiasis; Drug Evaluation; Drug Tolera | 1989 |
[The clinical study of fluconazole against pulmonary mycosis. Effects of fluconazole on pulmonary cryptococcosis and aspergillosis, and its pharmacokinetics in patients].
Topics: Adult; Aged; Antifungal Agents; Aspergillosis; Cryptococcosis; Drug Evaluation; Fluconazole; Half-Li | 1989 |
[Clinical efficacy of fluconazole in the patient with pulmonary mycosis].
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anorexia; Antifungal Agents; Aspergillosis; Cr | 1989 |
[Clinical evaluation of fluconazole in patients with mycotic infection].
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillosis; Aspergillus; Candidiasis; Candidia | 1989 |
[A clinical study of fluconazole in pulmonary aspergillosis].
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antibodies, Fungal; Antifungal Agents; Aspergi | 1989 |
[Fluconazole treatment of systemic mycoses].
Topics: Adolescent; Adult; Aged; Anorexia; Antifungal Agents; Candidiasis; Drug Evaluation; Drug Tolerance; | 1989 |
Treatment of murine histoplasmosis with UK 49,858 (fluconazole).
Topics: Animals; Antifungal Agents; Female; Fluconazole; Histoplasmosis; Ketoconazole; Lung Diseases, Fungal | 1986 |
Efficacy of fluconazole (UK-49,858) against experimental aspergillosis and cryptococcosis in mice.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus flavus; Aspergillus fumigatus | 1987 |